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ABSTRACT 
Alteration of serum tryptophan leads to parallel alterations in 
brain tryptophan levels. Such changes in brain tryptophan 
levels has been shown to lead to mood disturbances. The primary 
enzyme responsible for altering serum tryptophan levels is the 
liver cytosolic enzyme, tryptophan pyrrolase. Activation of 
this enzyme is responsible for the enhanced catabolism of 
circulating tryptophan. 
The purpose of the present study was firstly to establish 
whether there is a link between sex steroids and tryptophan 
pyrrolase activity especially since sex steroids are also known 
to cause mood disturbances and secondly to determine the effects 
of sex steroids on brain indolamine metabolism. 
The results show that all three sex steroids induce the activity 
of tryptophan pyrrolase implying that they decrease serum 
tryptophan levels by the activation of tryptophan pyrrolase, 
thus making less tryptophan available for uptake by the brain. 
It was also shown that the sex steroids enhance the uptake of 
14c-tryptophan by brain synatopsomes. In addition, the sex 
steroids influenced the pattern of metabolism of serotonin by 
organ cultures of rat pineal glands. 
It is possible that the sex steroids regulate the availability 
and uptake of indoleamines in the brain. 
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CHAPTER 1 
LITERATURE REVIEW 
1.1 HISTORY OF PINEAL RESEARCH 
The history of the pineal gland has been fraught with events 
which were as exciting as they were intriguing, almost bordering 
on the fringes of mystery. 
Galen, writing in the second century A.D., quoted stUdies of 
earlier Greek anatomists, particularly Heropilos (325-280 B.C.), 
who were impressed with the fact that the pineal was perched 
atop the aqueduct of the cerebrum and was a single structure 
rather than a paired one; he concluded that it served as a 
valve to regulate the flow of thought out of its 'storage bin' 
in the lateral ventricles of the brain. Rene Descartes (1596-
1650) embellished this notion; he believed that the pineal 
housed the seat of the rational soul. In his formulation, the 
eyes perceived the events of the real world and transmitted 
these to the pineal by way of "strings" in the brain. The 
pineal responded by allowing humours to pass down hollow tubes 
to the muscles, where they produced the appropriate responses. 
This mechanistic theory of perception by Descartes may be 
primitive, but one cannot fail to admire this prophetic 
formulation of the pineal as a neuroendocrine transducer with 
the hindsight of 300 years of pineal research. 
In the late 19th and early 20th centuries, the pineal fell from 
2 
its exalted metaphysical state. otto Heubner (1898), a German 
physician, published a case study of a young boy who had 
precocious puberty and was also found to have a pineal tumour. 
Prior to this, De Graaf (1886), Horschelt and Spencer (1905) 
have reported on the phylogenetic regression of the pineal 
gland. Studmika (1905) similarly reported that the pineal 
develops from a photoreceptor into a complicated gland having an 
enigmatic function. Berblinger (1920) and Engel (1936) further 
observed the antigonadotropic effects of the pineal gland. All 
the foregoing references were cited from The Pineal Gland, 
Wurtman and Axelrod (1965). 
1.1.1 ENDOCRINE FUNCTIONS OF THE PINEAL GLAHD 
Beyond a few years back, the state of knowledge about the gland 
was 
(i) it appeared to be a photoreceptor in the frog (Nils 
Holmgren, 1918) 
(ii) it had something to do with sexual function in rats 
and in humans 
(iii ) it contained a factor that blanched pigment cells in 
the tadpole (McCord and Allen, 1927). 
with the discovery of the endocrine glands by Claude Bernard 
(1813-1878) and Brown-Sequard (1817-1894) and the subsequent 
intensive research over the years, it became evident that it 
would be incorrect to define the pineal gland from the concept 
of a pure gland without taking into account its endocrine 
3 
functions. The term neuroendocrine transducer means an organ 
that secretes its own hormone in response to a locally released 
neutrotransmitter. In view of the various classical functions 
of the pineal, this definitive term seemed more appropriate in 
describing the pineal gland. The role of the pineal gland 
appears to convert a neural input, nonadrenaline released from 
sympathetic neurons into a hormonal output, melatonin. 
1.2 PINEAL ANATOMY 
1.2 . 1 LOCATION AND STRUCTURE 
Ariens Kappers (1960) published a meticulous study that 
demonstrated that although the pineal gland originates from the 
brain in the development of the embryo, it loses all nerve 
connections with the brain soon after birth. The pineal gland 
of the rat is superficially situated in the brain just rostral 
to the cerebellum and between the occipital poles of the 
cerebral hermispheres. Dorsally, it is covered by the 
confluence of the superior sagittal and transverse sinuses. The 
anlage of the pineal diverticulum lies in the dorsal median area 
of the neural tube at the level of the neuroaxis, which will 
become the diencephalon. The diverticulum characteristically 
originates in the area between the posterior and habenular 
commissures i.e. an intercommissural position (Bergman, 1965). 
Although definitively, the pineal is an azygous midline 
structure, in the strictest sense there are actually two pineal 
anlagen, one on either neural fold of the developing neural tube 
4 
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(Reiter, 1981) . The pinealocytes, the endocrine units, are not 
randomly arranged in the pineal gland (Vollrath, 1981 and 1984) . 
Connective tissue septae, which are continuous with the capsule 
of the gland, separate the parenchymal cells into cords or 
lobules, the lobules may appear as follicles. 
1.2.2 HISTOLOGICAL VARIATIONS IN HUMANS 
There is great individual variation in the histological 
appearance of the human pineal gland and this variability 
becomes even more evident with age (Reiter, 1989). In advanced 
age the connective tissue septae typically become more prominent 
and in many individuals calcified structures - concretions, 
corpora arenacea, calcium deposits - appear (Welsh, 1985) . The 
functional significance of these structures remains unknown, 
although in experimental animals, both the development and the 
persistence of the corpora arenacea require that the sympathetic 
innervation of the pineal gland remain intact (Champney et ai., 
1985) . 
1. 2. 3 THE PINEAL CELL 
There are two categories of pinealocytes and although these can 
be easily identified, there is a considerable confusion in the 
nomenclature owing to ignorance of exact pineal function. The 
pineal gland is chiefly composed of the first category of cells: 
light parenchymal pinealocytes which are characterized by the 
presence of granular ves i cles. Phylogenetically, Pevet and 
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Collin (1976), have shown that the cells originated from the 
neurosensory photorec eptor cells present in the pineal organ of 
submammalian vertebrates (Collin, 1971a and 1971b), and that 
they belong to the sensory cell line as defined by Collin 
(1971). In consequence, this category of cells can be termed 
true pinealocytes or pinealocytes sensu stricto (Wolfe, 1965). 
The second category of pineal parenchyma cells, called 
interstitial or glial cells are characterized by their location 
to the peri vascular space and absence of granular vesicles 
(Pevet, 1977) . The granular vesicles in the pinealocyte proper 
are believed to store the antigonadrotropic hormones (Upson et 
al., 1976). 
1.2 . 4 ULTRASTRUCTURE OF THE PINEAL CELL 
1.2.4.1 Cytopl.asm 
Four to twelve clusters of ribosomes are dispersed throughout 
the cytoplasm and form no 1 ink with the membranes. A few 
ribosomes are associated with paired cytoplasmic membranes and 
with the outer layer of the nuclear envelope to form the rough 
endoplasmic reticulum. Milofsky (1957) observed 'giant' 
mi tochondria which are fairly abundant in epiphyseal cells. The 
cytoplasm contains vern ate bodies in which variable numbers of 
glycogen particles, lipid droplets, mitochrondria, vesicles and 
grumose granules are present. 
Synaptic ribbons occur in the perikarya and polar processes of 
Wilde· crowned rodl" 
or ·,yn~ptic ribbon' 
ftucieof crf'OI' 
or fold 
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these cells, usually situated beneath the plasmalemma. 
Membranes of the Golgi apparatus occur randomly in the 
perikaryon of epiphyseal cells. The acanthosome or spiny body, 
is the only cytoplasmic organelle constantly associated with the 
Golgi apparatus, resul ting in invaginations resembling 
micropincytosis. Grumose globules, containing fine membranous 
and granular matter distributed evenly in the dense amorphous 
matrix are present but usually sparsely distributed. 
1.2.4.2 Nucleus 
The nuclear enveloppe consists of the usual perinuclear cisterna 
bridged by nuclear pores. Chromatin is localized in an uneven 
marginal zone sporadically confluent with areas deeper in the 
nucleus. Chromatin areas are filled with material arranged in 
meshworks, granular masses and helical strands . The nucleoli 
are composed of amorphous areas surrounded by a dense 
nucleolonema and ribonucleoprotein granules are present 
(Milofsky, 1958). 
1.3 NERVOUS INNERVATION 
The neural connections of the pineal gland have been of special 
interest because both the synthetic (Wurtman et al., 1965) and 
the endocrine (Reiter and Hester, 1966) capabilities of the 
gland rely on an intact sympathetic innervation. Early 
physiological (Thieblot et al., 1947) and anatomical data 
(Kappers, 1960) provided proof that the cell bodies of the 
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postganglionic sympathetic neurons were in the superior cervical 
ganglia and that processes of these cells terminated within the 
pineal gland. The course of the postganglionic fibres from the 
superior cervical ganglia to the pineal is via blood vessels 
(the internal carotid plexus). As the fibres near the gland, 
they enter the tentorium cerebelli and eventually form one or 
two relatively discrete nerves, the nervi cornarii, before 
entering the gland (Kappers, 1960). They usually penetrate the 
capsule near the distal end or apex of the gland. The · nerve 
fibres ramify among the pinealocytes and terminate especially in 
pericapillary spaces and occasionally between parenchymal cells 
(Romijn, 1973b; Matushima and Reiter, 1977). Contrary to an 
earlier view (Wolfe, 1965), in most species, the nerve terminals 
do not form morphological synapses with pinealocytes, rather 
they end primarily in the vicinity of pinealocyte processes, 
often around capillaries. 
1.4 TRANSLATION OF PHOTOPERIODIC INFORMATION INTO A CHEMICAL 
MESSENGER 
Unlike a number of other endocrine organs, the pineal gland 
relies heavily on its innervation for its endocrine activity 
(Reiter,1989). In particular, sensory information perceived by 
the eyes is essential in determining the production of pineal 
melatonin. The pineal gland is the site at which light:dark 
information is translated, or transduced, into a chemical 
messenger (Reiter, 1991b) . In general, light suppresses 
melatonin production, whereas darkness is associated with the 
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biosynthesis of several indoleamines (Reiter, 1984) . 
Information about ambient lighting conditions is transferred 
from the retinas to the pineal gland over a complex series of 
neurons that are located in both the central and peripheral 
nervous system (Kappers, 1965). This neuronal route includes 
the retinohypothalamic tract, the suprachiasmatic nuclei (SeN), 
and the pre- and postganglionic fibres of the peripheral 
sympathetic nervous system (Reiter, 1981). 
After transduction into a neural signal in the photoreceptors of 
the retinas, the message is sent to the hypothalmus via ganglion 
cell axons, which form the retinohypothalamic tract (Moore, 
1978). At the level of the optic chiasma these fibres diverge 
from the classic optic system and terminate in the 
suprachiasmatic nuclei of the anterior hypothalamus (Sonofriew 
and Weindl, 1982). After synapsing in this location, fibres 
project possibly to the paraventricular nuclei of the 
hypothalamus (Bittman, 1984). Long descending actions then 
supposedly carry the neural message to the intermediolateral 
cell column of the upper thoracic spinal cord (Swanson and 
Sawchenki, 1983). The axons of these preganglionic perikarya 
leave the spinal cord and pass up the sympathetic trunk to 
synapse on postganglionic cell bodies in the superior cervical 
ganglia; the postganglionic fibres enter the skull and among 
other organs, terminate within the pineal gland (Kappers, 1965). 
The melatonin synthetic and secretory activity of the pineal 
gland is determined primarily by the release of noradrenaline 
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nections between the eyes and the pineal. In the pinealocyte is a 
summary of the uptake of tryptophan and its conversion to and 
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(Axelrod, 1974) from the postganglionic sympathetic nerve 
endings. 
The sympathetic neural connections between the SCN and the 
pineal gland must remain intact in order for the pineal to 
function in its normal capacity. Interruption of the neural 
connection caudal to the SCN in either the central or peripheral 
nervous systems interferes with the cyclic production of 
melatonin as well as with the endocrine capability of the pineal 
gland (Kreisley and Moskowitz, 1978). 
1.5 THE BIOCHEMISTRY OF THE PINEAL GLAND 
1 . 5.1 CIRCADIAN RHYTHMS AND THE PINEAL GLAND 
Pineal function and pineal biochemistry are linked by one 
general theme; the function and biochemistry involve circadian 
rhythms. Circadian rhythms are found in the metabolic pathways 
of the pineal gland and circadian rhythms have been implicated 
in three areas of pineal function: control of locomotor 
acti vi ty, circadian time measurements in photoperiodism, and 
colour changes. 
Gaston and Menaher (1968) suggested that the pineal gland was a 
possible "biological clock" or "circadian pacemaker" after 
observing that the pineal gland was necessary for the normal 
persistence of locomotor activity in house sparrows. This 
result was verified in white-crowned sparrows (McMillan, 1972), 
lizards (Underwood, 1977), 
Rutledge, 1978). Although, 
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and starlings (Gwinner 
pinealectomy did not 
1978; 
abolish 
circadian rhythms of locomotor activity in chickens (MacBride, 
1973) or in rats (Quay, 1968), it did produce faster phase 
shifting in rats (Quay, 1968; Kincl et al., 1970) . 
Reiter (1977) proposed that the pineal gland of hamsters may be 
the source of antigonadal hormone which plays a role in the 
photoperiod response; hamster testes regress in constant dark 
or on short days, an effect which is reversed by pinealectomy. 
Reiter (1977) further postulated that melatonin may be one of 
the antigonadal hormones responsible for this effect. 
Photoperiodism in the hamster reproductive system is dependent 
upon circadian rhythms for time measurement (Elliot, 1972 and 
1976). 
1.5.2 MELATONIN 
McCord and Allen in 1917 discovered that extracts from bovine 
pineals contained a substance which lightened the skin colour of 
amphibians . Lerner and coworkers (1958) isolated this substance 
which they characterized as N-acetyl-5-methoxytryptamine (Lerner 
et; al., 1959; Lerner et al., 1960) and was termed melatonin 
because of its blanching effect on melanophores. Its synthesis 
undergoes a diurnal variation in relation to the photoperiod, 
the level being highest during the dark phase of the photoperiod 
(Wurtman et al . , 1968). 
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1.5.2.1 Tissue distribution 
Most of the melatonin in mammals is localized in the pineal 
gland . Since it is very lipophilic, its access to the CNS is 
not impeded by a blood brain barrier. 
In addition to the pineal, other endocrine tissues, peripheral 
nerves and the sympathetic nervous chain also selectively take 
up labelled melatonin, but to a lesser extent. Adipose tissue 
contains the lowest concentration of 3H-melatonin of any tissue, 
which indicates that the ability of such organs as the ovary , 
pineal and adrenal to concentrate the indole is unrelated to 
their relatively high lipid contents (Wurtman et al., 1964b) . 
other tissue/organs of the mammal in which the presence of 
melatonin has been established include peripheral nerves 
(Barchas and Lerner, 1964), brain (Wurtman, 1969 ; Koop et al., 
1980), lactating mammary tissue (Reppert and Klein, 1978), 
retina and Harderian gland (Bubenik et al., 1978; Pang et al., 
1980). Cardinali et al., (1972) have also established that 60-
80% of melatonin in the plasma is bound to serum albumin. There 
exists a state of dynamic equilibrium between "free" tryptophan 
and tryptophan bound to serum albumin. 
1.5.3 
1.5.3.1 
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BIOSYNTHESIS OF PINEAL INDOLES 
Melatonin 
The ability of the pineal gland to produce large quantities of 
methoxyindoles is related at least partially to the high levels 
of tryptophan hydroxylase within the pineal gland (Lovenberg et 
a1., 1967; Deguchi, 1977). After the uptake of the amino acid 
in the pinealocyte the hydroxylating enzyme converts it to 5-
hydroxy tryptophan. Following this step 5-hydroxytryptophan is 
decarboxylated by the enzyme L-aromatic amino acid 
decarboxylase, which is rather widely distributed in the 
organism (Lovenberg et a1., 1962). This reaction results in the 
formation of serotonin, the content of this amine is higher in 
pineal gland than in any other organ in the body (Quay, 1963; 
Saavedra et a1., 1973). Serotonin is the common precursor of a 
number of indoles formed within the pineal gland. In a 2-step 
process, serotonin is N-acetylated by the enzyme SNAT (Klein et 
a1., 1971; Buda and Klein, 1975). The product of this reaction 
is N-acetylserotonin. This step requires an acetyl group which 
is provided by acetyl CoA. The formation of melatonin from N-
acetylserotonin is catalyzed by the enzyme HIOHT (Axelrod and 
weissbach, 1960; Axelrod et a1., 1965). During this conversion, 
the methyl group is provided by 5-adenosylmethionine (Axelrod 
and Weissbach, 1960). 
The conversion of serotonin to melatonin is under control of 
light:dark cycle to which the animals are exposed via its action 
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on the peripheral sympathetic nervous system (Reiter, 1981). 
Characteristically, periods of light are associated with high 
pineal serotonin levels (Quay, 1963, 1966) and low SNAT activity 
(Klein and Weller, 1970; Rudeen et al., 1975). Conversely, 
during the daily period of darkness the amount of serotonin 
within the gland is diminished, presumably because it is being 
converted to N-acetylserotonin by the increased activity of the 
acetylating enzyme (Reiter, 1981). The magnitude of the 
day: night change in NAT acti vi ty varies among species: uniformly 
however, darkness is associated with the rise in the activity of 
this enzyme (Klein et al., 1971a; Deguchi and Axelrod, 1972; 
Rudeen et al., 1975). As a consequence of the increased SNAT 
activity at night pineal levels of N-acetylserotonin are also 
augmented (Klein and Weller, 1973). 
Considering the large amplitude rhythm in the activity of the 
acetylating enzyme throughout each 24-hour period, it has been 
proposed as the rate-limiting enzyme in melatonin production 
(Klein and Weller, 1973); but other workers (Wurtman and Ozaki, 
1978) dispute this. HIOMT, the enzyme that catalyzes the 
conversion of N-actylserotonin to melatonin, was initially 
thought to exhibit a circadian rhythm as well (Wurtman et al., 
1963). However, it is now conceded that if it does vary 
throughout the 24-hour period, the rhythm is of very low 
magnitude (Klein et al., 1981). 
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1.5.3.2 Synthesis of other pineal indoles 
serotonin is converted to 5-hydroxyindole acetaldehyde by 
monoamine oxidase (Axelrod et a1., 1969). 
converted to 5-hydroxyindoleacetic 
Some of this is then 
acid by aldehyde 
dehydrogenase (Wurtman and Larin, 1968; Lerner and Case, 1960). 
This is then O-methylated in the 5 position by HIOMT to form 5-
methoxyindole acetic acid (Wurtman and Axelrod, 1967) . Some of 
the 5-hydroxyindole acetaldehyde is also converted to 5-
hydroxytryptophol by alcohol dehydrogenase (McIsaac and Page, 
1959) and is then methoxylated by HIOMT to form 5-
methoxytryptophol (Wurtman and Axelrod, 1967). Serotonin can 
also be methoxylated by HIOMT to form 5-methoxytryptamine . 
1.5.3 . 3 The role of 6- and a-adrenergic mechanisms in 
melatonin production 
The a- and 6-receptors exhibit 24h rhythms in their density 
(Pangerl et a1., 1990); such flunctuations are generally 
believed to be determined by NE itself which, following its 
release causes the desensitization or internalization of the 
receptors (Romero et a1., 1975; Gonzalez-Brito et a1., 1988; 
Panger 1 et a1., 1989). The involvement of two receptors in the 
regulation of intracellular cAMP, is a feature common to many 
cells (Reiter, 1991). cAMP is the essential intracellular 
second messenger required for the rise in nocturnal melatonin 
production (Axelrod, 1974; Klein et a1., 1981; Santana et a1., 
1988) . 
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B-adrenergic stimulation of the pinealocyte causes a rise in 
intracellular accumulation of cAMP due to its ability to 
increase the acti vi ty of adenyl ate cyclase (0' Dea and Zatz, 
1976). Activation of B-adrenergic receptors alone induces up to 
10-fold increase in cAMP in the pineal gland, conversely 
stimulation of a-adrenergic receptors alone is without any 
effect on cyclic nucleotide accumulation (Vanecek et al., 1985). 
However, when combined stimulation of both B- and a-adrenergic 
receptors by NE occurs, the rat pineal response in terms of cAMP 
is greatly potentiated with nucleotide content increasing up to 
100-fold . (Klein, 1985). These findings are consistent with the 
view that, in the pinealocyte, B-receptors activation is a 
requirement for cAMP accumulation with a-receptor stimulation 
amplifying the response. The dual receptor regulation of cAMP 
in the pineal gland also translates into a similar stimulation 
(by B-adrenergic receptors) and augmentation (by a-adrenergic 
receptors) of the activity of the rate-limiting enzyme in 
melatonin production, N-acetyltransferase (Klein et al., 1981), 
as well as of melatonin itself (Santana et al., 1988). 
By observing the fact that ribosylation of the G-protein by 
cholera toxin can substi tute for B-adrenergic receptor 
activation (Sungden, 1989), it was believed that a G-protein is 
involved in the B-receptor-mediated stimulation of adenyl ate 
cyclase. 
Stimulation of a.-receptors increases both the diacylglycerol 
and intracellular calcium concentrations: these two processes, 
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in a synergistic manner, stimulate the translocation of protein 
kinase C(PKC) (Sugden, 1989) . The resultant activation of PKC 
increases the efficiency of activation of adenyl ate cyclase most 
probably through phosphorylation of the cyclase (Reiter, 1991). 
a-adrenergic receptor stimulation only slightly augments the 
actual amount of melatonin formed, which is essentially a result 
of B-adrenergic receptor stimulation (Reiter, 1991). Thus 
marked interactive effect of B- and a-adrenergic stimulation of 
the second messenger cAMP does not carryover it a similar large 
augmentation of the amount of melatonin formed (Reiter, 1991). 
1.5.3.4 Factors affecting melatonin synthesis 
1.5.3.4.1 Drug effects 
1.5.3.4.1.1 Catecholaminergic drugs 
Axelrod et al., (1969) have shown that the rate at which 
cultured rat pineals synthesize HC-melatonin from UC-tryptophan 
is increased by catecholaminergic drugs, such as d-
noradrenaline, I-epinephrine, dopamine, tyramine, octopamine and 
tryptamine. Catecholaminergic drugs influence the release of 
noradrenaline from the sympathetic nerves innervating the pineal 
gland and hence these drugs exert a positive influence on 
melatonin synthesis. In addition, pheniprazine (Axelrod et al., 
1969) and harmine (Klein and Rowe, 1970), all MAO inhibitors 
have been observed to influence melatonin synthesis. 
1.5.3.4.1.2 
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Psychotomimetic drugs 
These drugs which include dimethyltryptamine, bufotenine, 
mescaline, lysergic acid diethylamide (LSD) and 
dimethoxyphenylethylamine (Hartley and smith, 1973) as well as 
amphetamine (Backstrom and Wetterberg, 1973) and cocaine (Holtz 
et al . , 1974) are all known to increase melatonin synthesis . 
However, neuroleptics have been found to decrease this synthesis 
(Hartley et al . , 1972). 
1.5 . 3.4.1.3 The adrenergic blockers 
Wurtman et al . , (1971) had shown that B-adrenergic blockers, 
such as propranolol can block the noradrenaline-induced increase 
in melatonin synthesis in cuI tured rat pineals. 
Phenoxybenzamine showed no effect. Wurtman et al., (1974) 
further observed that neither propranolol nor phenoxybenzamine 
could affect the increase in melatonin synthesis caused by 
dibutyryl cAMP. However, cycloheximide, a protein synthesis 
inhibitor and actinomycin block this effect (Berg and Klein, 
1971) . 
1 . 5.3.4.1.4 sympathomimetics and related agents 
The effects of sympathomimetic drugs on the rat pineal gland 
have been exhaustively investigated. Fiske (1964) and Klein et 
al . , (1971) have established that, denervation, by bilateral 
superior cervical ganglionec tomy abolishes the nocturnal rise in 
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indoleamine metabolism. Axelrod et ai., (1969) and Klein et 
ai., (1970) also established the converse observation that, 
addi tion of norepinephrine to cultured glands increases the 
synthesis and secretion of melatonin. The actions of 
norepinephrine are mediated by the B-adrenergic receptor 
(Wurtman et ai., 1971; Deguchi and Axelrod, 1972a). In 
contrast, other neurotransmitters, though present in the gland, 
are ineffective in stimulating the gland. These include 
serotonin (Klein and Weller, 1973; Deguchi and Axelrod, 1972a), 
GABA (Mata et ai., 1976) and histamine (Klein and Weller, 1973). 
Other agents which usually are not thought of as 
sympathomimetics, can still stimulate the pineal through weak 
interaction with the B-adrenergic receptors. Examples include 
taurine (Wheler et ai., 1979), octopamine (Klein and Weller, 
1973) and possibly DOPA (Deguchi and Axelrod, 1972a; Lynch et 
ai., 1973). 
Agents which by-pass the B-adrenergic receptor have also been 
useful in elucidating regUlatory mechanisms. 
activity by cAMP analogues (Klein et ai., 
Induction of SNAT 
1970; Deguchi and 
Axelrod, 1972b) and by phosphodiesterase inhibitors (Klein and 
Weller, 1973; Deguchi and Axelrod, 1972) strengthens the 
conclusion that cAMP mediates the effects of B-adrenergic 
stimulation. Agents which block the B-adrenergic receptors, or 
result in reduced concentration of norepinephrine at the 
receptors, have been shown to block the stimulation of 
indoleamine metabolism. Such agents include reserpine (Deguchi 
and Axelrod, 1972b) which depletes the sympathetic nerve endings 
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of catecholamines, and propranolol (Deguchi and Axelrod, 1972b; 
Parfitt et al., 1976), which specifically blocks the B-
adrenergic receptors. 
The B-adrenergic receptors are similarly blocked by 
dichloroisoprenaline and they are inhibited to some degree by 
trifluoperazine and chloropromazine but they are not affected by 
the alpha lytics:phentolamine and phenoxybenzamine (Weiss and 
Costa, 1968; Uzunov and Weiss, 1971). Auerbach et al., (1981) 
have shown that the relative potencies of norepinephrine and 
isoprenaline on pineal cyclic AMP levels appear to be dose-
dependent. The norepinephrine-induced elevation of cAMP 
activity is potentiated by introducing theophylline, a 
phosphodiesterase inhibitor to the culture medium (Strada et 
al., 1972). 
Probenecid blocks the cultures efflux of both cAMP and cGMP 
whilst desmethylimipramine blocks the stimulated accumulation 
and efflux of cGMP (O'Dea et al., 1976). Chloragen increases 
adenyl cyclase and cAMP levels and decreases cGMP levels in 
pineal organ cultures (Minneman, 1977). 
1.5 . 4 PINEAL ENZYMES 
Pineal enzymes represent five major categories on the basis of 
the nature of their catalytic effects: 
(i) oxidoreductases 
(ii) transferases 
(iii) 
(iv) 
(v) 
hydrolases 
lyases 
isomerases 
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Quay (1974) has compiled a detailed survey of pineal enzymes 
within each of these categories. 
1.5.4.1 Tryptophan-5- hydroxylase 
This enzyme hydroxylates tryptophan to 5-hydroxytryptophan . 
Hori et a1., (1976) demonstrated that the enzyme is localized in 
the mitochondrial fractions . Romijn et a1., (1977) observed in 
vitro, a spherical enlargement of the mitochondria in the light 
pinealocytes of rabbit after addition of p-chlorophenylalanine, 
an inhibitor of tryptophan-5-hydroxylase (Besinger et a1., 1974; 
Lovenberg et a1., 1967; Oeguchi and Barchas, 1972). 
1.5.4.2 serotonin H-acetyltransferase (SHAT) 
SNAT is metabolically the most important of the transferases in 
the pineal gland. SNAT (EC2.3.1.5., acety CoA: argylamine-N-
acetyltransferase), catalyzes the rate-limiting step in the 
pathway from 5-HT to its 5-methoxy derivatives. The pineal 
gland is a rich source of the enzyme system known as cAMP-
dependent protein kinase which includes a regulatory protein 
(cAMP-binding) and a catalytic protein (protein kinase). When 
activated by cAMP, this system phosphorylates histones. It has 
important roles in the induction of some pineal enzymes, 
including SNAT (Fontana and Lovenberg, 1971; Fontana and 
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Lovenberg, 1971; winters et al., 1977). 
SNAT activity in rat pineal cultures has been shown to be 
increased by noradrenaline (Klein et al . , 1971; Deguchi and 
Axelrod, 1973; Klein and Weller, 1973), DOPA (Deguchi and 
Axelrod, 1972) and isoprenaline (Deguchi, 1973), octopamine 
(Klein and Weller, 1970), theophylline and the MAO inhibitors 
pargyline and latron (Deguchi and Axelrod, 1972). Propranolol 
however abolished the rise in activity of SNAT by blocking the 
B-adrenergic receptors of the pineal cells. 
It appears that the retinohypothalamic projection is responsible 
for the synchronization of the circadian rhythm in pineal SNAT. 
Destruction of the suprachiasmatic nucleus abolished the rhythm 
in SNAT activity in the pineal gland. Evidently, the 
suprachiasmatic nucleus represents a central rhythm generator 
(Moore and Klein, 1974), an endogenous oscillator or biological 
clock (Klein, 1978) . 
The stimulatory effect of the catecholamine, norepinephrine on 
SNAT (Klein et al., 1970a, b) occurs only during the night 
(Shibuya et al., 1975; Klein and Weller, 1970) . In contrast to 
the maximal amount of norepinephrine present at the end of the 
night, the activity of SNAT decreases as the end of the night 
approaches . This may probably be explained in the following 
way: the sensitivity of the B- receptor increases during daytime 
(Romero and Axelrod, 1974, 1975). Since norepinephrine rapidly 
decreases during the daytime, cAMP is not produced in sufficient 
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quantity. After the onset of darkness, however, the increasing 
amount of norepinephrine produces a rapid increase in quantity 
of cAMP, although the maximal activity of SNAT during the night 
results in a high synthesis of N-acetylserotonin (Klein and 
Weller, 1970) . Lynch et al., (1973a) and Sampson (1975), have 
shown that rats immobilzed for several hours or made 
hypoglycaemic with insulin have high levels of melatonin as well 
as SNAT. These increases are due to the release of 
catecholamines from the sympathetic nerve terminals. 
1.5.4.3 Hydroxyindole-o-methyl transferase (HIOHT) 
This enzyme is responsible for the formation of: MIM from 
HIM; MTOH from HTOH and melatonin from N-acetylserotonin. 
Noradrenaline (Klein, 1969), when added to pineal cultures and 
dimethyl tryptamine (Hartley and Smith, 1973) when added to 
pineal homogenates, increase HIOMT activity. Administration of 
DOPA similarly increases HIOMT activity (Lynch et al., 1973). 
The inhibitors of HIOMT include substituted N-benzoyl tryptamines 
and N-phenylacetyltryptamines (Ho at al., 1971), haloperidol 
(Hartley et al., 1972; Ho et al., 1973), fluperazine, GABA 
(Hartley et al., 1972) and oxypertine (Ho et al., 1973). 
1.5.4.3.1 Effect of pteridines on HIOHT activity 
Cremer-Bartels (1962a, b), and Cremer-Bartels and Balazs (1973) 
have established the presence of pteridine-like pigments in the 
mammalian eye tissues. 
presence of pteridines 
mammalian pineal gland . 
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Ebels et a1., (1979) have also shown the 
and pteridine-like pigments in the 
Cremer-Bartels et a1 . , (1975), further 
observed that commercial triamterene (2,4,7-triamino-6-
phenylpteridine) affects retinal HIOMT in the process of light 
adaptation and therefore suggested that pteridines may play a 
role in the regulation of melatonin biosynthesis. The drug 
triamterene is applied in man and assumed to affect 
corticosteroid levels (Klein et a1., 1978). Melatonin itself, 
applied in rats, was shown experimentally to decrease the serum 
corticosteroid level (Minneman and wurtman, 1976). The 
combination of these two phenomena suggests that triamterene 
affects pineal HIOMT and in this way may be invol ved in 
endocrine regulation (Cremer-Bartels, 1979). 
1.5.5 ENDOCRINE EFFECTS OF THE PINEAL GLAND 
1.5.5.1 Effect on the pituitary gland 
1.5.5.1.1 The pineal gland and the regulation of gonadotropin 
secretion 
Kitay (1954), Kitay and Altschule (1954), and Wurtman et a1., 
(1959) have demonstrated the induction of ovarian hypertrophy 
following pinealectomy. The induction was inhibited by the 
injection of crude, or protein-free, pineal extracts. Data from 
numerous literature reports (Reiter, 1973; Altschule, 1975; 
Minneman and Wurtman, 1975; Relkin, 1976; Mess et a1., 1978) 
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have established the inhibitory role of the pineal gland on both 
FSH and LH. 
Fraschini et al., (1968a, b) demonstrated a significant increase 
in pituitary LH content following pinealectomy. The extent of 
this increase was about the same as that observed after 
castration. The implantation of pineal tissue or of melatonin 
into either the medium eminence or the reticular sUbstance of 
the mesencephalon equally depressed the castration-induced rise 
of pituitary LH. The fact that the implantation of melatonin or 
of some melatonin derivative into various locations within the 
brain stem inhibits LH secretion but not implantation of the 
same substances into the adenohypophysis, indicates that pineal 
hormone(s) act as sites within the central nervous system 
(Trentini et al., 1979) . 
Narang et al., (1967) and Vaughan et al . , (1971) reported a 
decrease in pituitary mass after melatonin administration . This 
was however not observed by De Prospo and Hurley (1971a). 
Melatonin administration has been shown to block the pre-
ovulatory surge in serum LH (Reiter and sorrentino, 1971; Ying 
and Fiske, 1972) as well as decrease serum FSH (Sorrentino, 
1968; Kamberi et al., 1971). 
Moszkowska et al . , (1973) put foward a mechanism to explain the 
above effects. They observed that microinjections of melatonin 
into the rat lateral ventricle resulted in a significant 
• 
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decrease in hypothalamic releasing factor (RF) levels, notably, 
FSH-RF content. They therefore suggested that melatonin may act 
by decreasing the synthesis or release of the gonadotropin RFs 
in the hypothalamus. This finding was consistent with the 
studies of Kamberi et al., (1970) who showed that melatonin 
injected directly into the pituitary gland had no effect on 
serum LH levels. However, there were contradictory reports by 
Martin et al., (1977) and Martin and Klein (1976), which show 
that melatonin can act directly on the neonatal pituitary gland 
and suppress the response to LH releasing hormone (LH-RH) which, 
in turn suppresses pi tui tary LH release. The inhibitory role of 
the pineal gland exerted on the TSH-thyroid system, ACTH-
adrenocortical mechanisms and GH-secretion is in many respects 
equivocal. The anti gonadotrophic activity of the pineal gland 
and its hormones seem to be more unequivocal . 
1.5.5.2 Adrenal glands 
1.5.5.2.1 Glucocorticoids 
The precise effect of melatonin administration on the production 
of ACTH and corticosterone are contradictory. Kinson and Singer 
(1967a, b) observed that pinealectomized rats secrete an 
increased amount of corticosterone and concluded that melatonin 
exerts an inhibitory effect on adrenal function. By contrast, 
Gromora et al., (1967a, b) were able to show that the acute 
administration of melatonin significantly elevated 
corticosterone levels. This effect, however, disappeared 
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following hypophysectomy which suggested that melatonin has a 
stimulatory effect on ACTH . Fraschini et al . , (1968) 
established that there was a 4ecrease in adrenal mass following 
intrahypothalamic implantation of melatonin . Barchas et al., 
(1969) however observed no correlation between chronic or acute 
parenteral melatonin administration and the plasma levels of 
corticosterone, ACTH or pi tui tary stores of ACTH. De Prospo and 
Hurley (1971a) injected melatonin (100~g/day) into the lateral 
cerebral ventricles of female rats for 10 days. The idea here 
was to increase the amount of melatonin gaining access to the 
neuroendocrine axis . The melatonin, however, failed to depress 
the pituitary-adrenal axis. 
contrary to these reports Motta et al., (1971) showed that an 
acute intraventricular injection of melatonin brought about a 
significant reduction in the levels of plasma corticosterone in 
normal male rats. Further work has established that melatonin 
similarly suppresses stress-induced corticosterone production . 
Following reserpine treatment, the corticosterone response was 
however not affected by melatonin treatment. These results 
suggest that ACTH is under inhibitory control by a central 
adrenergic mechanism (Giuliani et al., 1966) and that melatonin 
might possibly exert its actions via this inhibitory mechanism. 
A central action of melatonin is supported by the in vitro 
evidence, that when the hormone is added to pituitary incubates, 
it does not change ACTH secretion (Jouan and Samperez, 1965) . 
Melatonin has also been shown to alter the synthesis of 
corticosteroids in incubated adrenal slices (Giordano et al . , 
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1967, 1970). 
Daily intraperi tonal injections of melatonin (2 x 50 j.lgjday) 
stimulated adrenal 5-a-reductase activity in ovariectomized and 
hypophysectomized rats (Ogle and Kitay, 1977) suggesting that 
melatonin may play a role in the physiological regulation of 
adrenal steroidogenesis. 
In many diurnal species, maximum levels of cortisol, 
corticosterone and ACTH occur just before daylight and around 
the onset of darkness in nocturnally active rodents (Krieger, 
1979; Touitou et al., 1982; 1983). Different types of physical 
or psychological stress are able to cause ACTH release whereas 
cortisol and synthetic glucocorticoids inhibit ACTH secretion 
through a negative feedback mechanism. Neither 
pneumoencephalography, electroshock therapy, sleep deprivation, 
psychological stress nor sprinting, elevated melatonin secretion 
despite the activation of the HPA axis (Vaughan et al., 1979; 
Touitou et al., 1983). 
In a study of the effect of cortisol synthesis blockade by 
metyrapone, a drug which inhibits 11B-hydroxylase activity which 
resul ts in a fall in the production of cortisol, inducing a 
compensatory increase in ACTH secretion, Brisma et al., (1985) 
established that in two patients with asymptomatic moderate 
hyperparathyroidism and prolactin-secreting micro adenoma 
respectively, urinary melatonin levels remained unchanged 
whereas these levels increased in two heal thy volunteers. Medhi 
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and Sandor (1969), using bovine adrenal cortex in vitro 
demonstrated that melatonin inhibi ts the conversion of 
radiolabelled progesterone to cortisone and aldosterone. 
Komissarenko et al., (1979) also reported the inhibition of 
corticosteroidogenesis by an epiphyseal factor isolated from 
bovine pineal glands. 
All these reports suggest that the pineal gland may play a 
modulatory role in corticosteroidogenesis. 
1.5.5.2.2 Aldosterone 
Gromora et al (1967a and b) have demonstrated that the acute 
administration of melatonin significantly reduced aldosterone 
production, while hypophysectomy abolished this effect. Farrel 
(1959 and 1960) isolated two pineal extracts. The first which 
he named, adrenoglomerulotropin enhances aldosterone release. 
The second extract which bears close structural identity with 
melatonin (Farrel and McIsaac, 1960), inhibits aldosterone 
secretion. Haulica et al., (1980), have postulated the 
existence of positive and negative feedback relationships 
between the brain isorenin-angiotensin system (angiotensin II 
enhances the increase in serotonin levels in the pineal, the 
hypothalamus and the brain stem in dogs) and serotonin 
metabolism in the pineal gland. Earlier, Kinson et al., (1967) 
reported significant increases in aldosterone levels one month 
after pinealectomy. 
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In view of the contentious nature and contradictions in these 
foregoing reports, it would not be possible to draw a precise 
and justifiable conclusion on the influence of the pineal gland 
and its putative hormone, melatonin on the secretions of 
aldosterone. 
1.5.5.3 Thyroid Gland 
Vriend (1978) has recently formulated a relationship between 
pineal function and thyroid activity. This was as a result of 
his observation that, if pinealectomized hamsters are subjected 
to darkness, short photoperiods or blindness, their gonads do 
not involute and plasma thyroxine levels remain normal, in 
contrast to sham-operated controls in which depression of 
thyroxine levels and gonadal involution occur. 
Prior to this Milan et al., (1968) and Csaba and Bernard (1972) 
have respectively demonstrated that low concentrations of 
thyroxine in the incubation medium increased the activity of the 
enzymes in the glycolytic pathway and lipid metabolism of 
cultured pineal gland; and that thyroxine enhanced serotonin 
metabolism in the pineal organ cultures. Milne (1963) also 
suggested that the feedback information from the thyroid gland 
influences not only the hypothalamic- hypophyseal axis but also 
the habenular-pineal complex. This hypothesis has recently 
received support from observations on melatonin synthesis in 
incubated pineal glands. Nir and Hirschman (1978) reported that 
thyroxine or triidothyronine added to the incubation medium 
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increased He-tryptophan metabolism to melatonin and in the 
presence of 10mM norepinephrine, labelled precursor metabolism 
to N-acetylserotonin. 
hormone, the effects 
effects. 
At higher concentrations of thyroid 
were not observed, implying biphasic 
All these> reports suggest a direct influence of the thyroid 
gland on pineal function. On the other hand, the pineal gland 
appears, from previous reports to influence the physiological 
manifestations of the thyroid gland. Scepovic, (1963) 
demonstrated that the administration of pineal extract brings 
about a reduction in thyroid mass as well as '''1 accumulation by 
the thyroid gland and further that pinealectomy results in 
increased 1311 uptake. In a similar finding, Baschieri et al., 
(1963) showed that there was a significant reduction in 1311 
uptake by the thyroid gland after daily parenteral 
administration of melatonin. Singh and Turner, (1962) observed 
a reduction in thyroxine secretion in melatonin-treated rats. 
Another finding by Baschieri et al., (1963) which was confirmed 
by > Reiter et al., (1965) showed that melatonin blocked the 
thyroid hyperplasia caused by methyl thiouracil. Panda and 
Turner, (1968) reported that chronic melatonin administration 
brings about a reduction in pituitary levels and increase plasma 
levels of thyrotropic hormone. De Pros po et al . , (1968, 1969) 
similarly reported reduced 1311 uptake following melatonin 
administration which they found unrelated to the inhibitory 
effect of melatonin on gonadal secretions . 
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However, there have been a few reports which contradict the 
foregoing reports on melatonin effects on the thyroid. Naber et 
al., (1969) demonstrated that melatonin did not affect 1311 
uptake into the thyroid gland. Thieblot et al., (1966) showed 
that melatonin administered to prepuberal rats produces marked 
hypertrophy of the thyroid gland. Narang et al., (1967) found 
that the TH secretion rate in rats was inhibited by chronic 
melatonin administration. Gordon et al., (1980) have 
demonstrated that chronic melatonin increases the thyroid gland 
size and thyroxine content of the thyroid. 
The view of the various workers on the effect of pineal function 
on the thyroid is that the pineal plays a modulatory role on the 
thyroid with respect to the release of TH. 
1.5.5.4 Prolactin 
Melatonin (500~g, twice daily for six days) is required from an 
intact pineal gland to augment serum prolactin level inasmuch as 
the effect of the indoleamine was negated by pinealectomy 
(Cardinali et al., 1979). Increased prolactin release into 
circulation was observed (Kamberi et: al., 1971) following 
melatonin administration into the rat cerebral ventricles. This 
effect was not observed when melatonin was injected directly 
into the anterior pituitary and therefore the workers suggested 
that melatonin might block the release of prolactin inhibiting 
factor (dopamine) from the hypothalamus which in turn would 
explain the observed elevation in plasma levels of prolactin (Lu 
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and Meites, 1973). The intravenous administration of 5-HTP or 
5-HT raises serum prolactin levels and the diurnal changes in 
prolactin secretion run parallel to pineal activity. Prolactin 
levels are high during the dark period (Willonghby, 1980). 
Pinealectomy does not affect the diurnal rhythm but it delays 
the fall in the mean prolactin concentration occuring during the 
light period (Niles et al., 1977). The reduced levels of 
prolactin caused by 5-MTOH and N-acetylserotonin in intact rats 
were abolished by pinealectomy. Of the various compounds 
studied for their effects on prolactin secretion, melatonin was 
found to influence the secretion of prolactin. Arginine 
vasotocin, a polypeptide with antigonadotropic properties also 
induced prolactin secretion in a biphasic manner. serotonin and 
5-HTP showed no effect on prolactin secretion (Hanen et ai., 
1980) . 
From these reports, it can be suggested that the pineal gland 
can influence prolactin secretion. 
1.5.5.5 Growth Hormone (GH) 
MaIm et ai., (1959) observed an increase in body weight of 
pinealectomized rats . Prior to this it has been known that 
total darkness or blinding inhibits the growth of rats (Luce-
Clausen and Brown, 1939). Giammanco et ai . , (1968) later showed 
that anosmia provokes the same growth-retarding effect. Relkin 
(1972b) demonstrated decreased pituitary and plasma GH levels 
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and retarded body growth in animals exposed to constant 
darkness. This effect was abolished by pinealectomy. 
Ronnelkeiv and McCann (1978) found that pinealectomy reduces the 
level of GH during the day but not in the night. Smythe and 
Lazarus, (1973) concluded from a series of studies that the 
abili ty of melatonin to increase serum GH in man is due to 
interaction with serotonin receptor sites in the hypothalamus 
which, in turn, induces the release of GH from the pituitary. 
They postulated that melatonin can act as a blocker or 
competitive antagonist at serotonin receptor sites. This might 
explain why melatonin and serotonin have opposite effects on GH 
secretion. 
1.5.5.6 Melanocyte-stimulating Hormone (MSH) and Melanocyte-
stimulating Hormone Release-Inhibiting factor (MIF) 
Kastin and Schally (1967) found that melatonin decreased 
pituitary MSH. They suggested that the release of MSH from rat 
pi tui taries is stimulated by an increased concentration of 
circulating melatonin and inhibited by raised levels of 
circulating MSH. 
The exact mechanism is not clear but Kastin et a1., (1972b) 
proposed a possible link between the pineal gland, hypothalamus 
and pituitary involving melatonin, MSH and MIF. 
Tilders and Smelik (1975) however found no relationship between 
melatonin administration and pituitary MSH. From an earlier 
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observation by Tilders (1973) that melatonin has no effect on 
diurnal variation of pituitary MSH levels, Tilders and Smelik 
(1975) concluded that the rhythm as well as resting MSH levels 
were not controlled by melatonin. 
1.6 GONADAL SEX STEROIDS AND THE PINEAL GLAND 
1.6.1 INTRODUCTION TO STEROIDS 
1.6.1.1 Definition of Steroids 
steroids are a class of organic compounds biologically derived 
from six isopentyl pyrophosphate units and containing the 
perhydrocyclopentanephenanthrene nucleus i. e. three six-membered 
rings and one five-membered ring. 
1.6.2 THE STEROID CYCLE 
At present, steroid hormone production is believed to be 
initiated by the releasing factors of the hypothalamus of the 
brain which travel to the anterior lobe of the hypophysis 
(pituitary gland) in the portal blood stream of the pituitary 
stalk, where they cause the secretions of trophic hormone into 
the blood stream. The trophic hormone travels to the sight of 
steroid synthesis e.g. adrenal gland, ovary, testes, and 
stimulates the production of steroids which are released into 
the blood stream to travel to the target organ e.g. kidney and 
skin. It is believed that steroids are transformed in the 
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target cells and metabolites released into the blood stream. 
steroids are further degraded and rendered inactive at special 
degrading sites e.g. liver and are then excreted. 
There is a feedback inhibition system whereby no releasing 
factor is produced when the blood steroid levels are too high. 
Each type of steroid hormone is believed to have its own steroid 
cycle, the nomenclature of which is based on the organ of the 
site of synthesis e.g. the corticosteroid cycle is initiated by 
the corticotrophin releasing factor which causes the release of 
the (adreno-)corticotrophic hormone (corticotrophin or ACTH), 
which in turn stimulates the cortex of the adrenal gland to 
produce corticosteroids. Similarly, luteotrophin releasing 
factor causes the release of the luteotrophic hormone, and this 
stimulates the corpus luteum of the ovary to produce its 
steroids . The evidence for feeback inhibitions by androgens and 
estrogens is still not conclusive, although oral contraceptives 
are belived to act by suppressing the hypothalamic releasing 
factors (Briggs and Brotherton, 1970). 
1.6.3 EFFECT OF GONADAL SEX STEROIDS ON PINEAL MORPHOLOGY 
AND ADENYL CYCLASE 
Histochemical and ultrastructural studies of chicks injected 
with the sex steroids suggested that the sex steroids influence 
precocious maturity of the pineal gland (Boya et al., 1980). 
The pineal adenyl cyclase system of ovariectomized rats was 
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found to be more susceptible to stimulation by noradrenaline. 
Prior to this Weiss and Crayton (1970) have shown that 
noradrenaline exerts a higher level of stimulation of male rats 
than female rats. The adenyl cyclase system is inhibited by 
chronic administration of estradiol . Testosterone and 
progesterone has no such effect on the system. 
1.6.4 ESTRADIOL [1.3.5(10)-Estratrien-3, 17a-diol] 
Zweens, (1965) reported the reversal of the pineal lipid content 
that followed ovariectomy in rats. since then estradiol 
treatment in rats has been reported to influence a number of 
pineal constituents, including size and matrix of pinealocyte 
mitochondria (Clementi et al., 1965), nucleic acid and protein 
content (Nir et al., 1970; Nir et al., 1972), protein synthesis 
(Cardinali et al., 1974), 5-HT and NE turn over rates (Vacas and 
Cardinali, 1980; Cardinali et al., 1975), NE-induced increase of 
adenyl ate cyclase activity (Weiss and Crayton, 1970) and of cAMP 
content (Davis, 1978), NE-induced changes of pinealocyte 
electrical activity (Marks et al., 1972), HIOMT levels (Wurtman 
et al., 1965; Cardinali et al., 1974; Wallen and Yochim, 1974) 
and melatonin release in vivo, (Ozaki and Wurtman, 1978) and in 
vitro (Wilkinson and Arendt, 1978). 
Two groups of workers (Marks et al., 1972; Nagle et al., 1972), 
independently reported indications about the existence of 
receptors for estradiol in the rat pinealocyte. The first group 
reported that 3H-estradiol was bound to soluble macromolecules 
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by pineal homogenates in vitro whilst the second group reported 
that pineal glands of oophorectomized rats, given a pulse 
injection of 3H-estradiol took up and retained the labelled 
steroid to the same extent as the uterus. 
David et ai., (1975) have demonstrated the 3H-estradiol uptake 
in vivo and in vitro and its binding to receptor proteins in 
rhesus moneky pineal glands resembling those of rats. This 
finding was confirmed a year later by Murthy et al., (1976) who 
reported the 3H-estradiol binding to cytosol proteins. 
Autographic analysis of rat pineal glands after in vivo 
administration of 3H-estradiol revealed nuclear concentrations 
of labelled grains in still undefined population of pineal 
cells. Even though this finding is compatible w:\,th the 
biochemical data on cytoplasmic and nuclear estraphillic 
receptors, it is not clear whether these cells are pinealocytes 
or glial cells (Vernadakis et ai., 1978). These reports confirm 
the presence of specific estradiol receptors on the pinealocyte. 
1.6.4.1 Effect of estradiol on pineal enzymes 
1. 6.4.1.1 HIOMT 
l'Iurtman et ai., (1965a) found that there was a significant 
decrease of pineal HIOMT activity 24 hours after a single dose 
of 10~g of estradiol benzoate administration to ovariectomized 
rats . Alexander et ai., (1970) injected 50~g of estradiol for 
3 days and found that this inhibited the postcastration rise of 
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pineal HIOMT activity in rats oophorectomized at the twenty-
eighth day of life and sacrificed three weeks later. Cardinali, 
(1977) determined that 2~g of estradiol should be taken as the 
highest dose to be injected to examine changes in pineal 
activity within the physiological range, since the injection of 
2~g of estradiol into ovariectomized rats produced translocation 
of pineal hormone-receptor complexes from cytoplasm to nuclei 
indistinguishable from normal rats in proestrus. 
It is rather important to distinguish between pharmacological 
and physiological concentrations of estradiol in studies 
relating to pineal functions. 
Cardinali et al., (1974) reported that administration of 0,05-
1,0~g/day of estradiol for three days increased HIOMT activity 
whereas greater pharmacological doses (5~g/day) decreased it 
(Nagle et al., 1972). Administration of the weak estrogen, 
estrone, in a dose of 10~g restores the mean rate of pineal 
HIOMT activity depressed following ovariectomy in female cycling 
rats (Wallen and Yochim, 1974); therefore these doses of 
estrone seem to mimic low rather than high doses of estradiol. 
The conclusion from these reports is, estradiol appears to exert 
a biphasic, dose-dependent effect on pineal HIOMT activity in 
rats; low doses being stimulatory and high doses being 
inhibitory. 
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1. 6 . 4 • 1. 2 SNAT 
Against the backdrop of the fact that estradiol has definite 
effects on the NE activation of adenylate cyclase (Weiss and 
Crayton, 1970), it is surprising that SNAT does not respond to 
estradiol treatment as has been suggested by numerous reports. 
Illnerova, (1975) found that estradiol administration did not 
alter light-dark cycles of SNAT nor its induction by 
isoprenaline in vivo. Wilkinson and Arendt, (1978) also 
reported that 
ovariectomized 
the 
adult 
estrogen-progesterone priming of 
rats resulted in marginal although 
significant increase of SNAT sensitivity to isoprenaline in 
vitro. Again estradiol treatment in corturnix quail, did not 
affect pineal SNAT activity (Preslock, 1977). These reports 
suggest that estradiol has no effect on pineal SNAT activity. 
1.6.4.1.3 MAO 
Vacas and Cardinali, (1980) reported that there was a decrease 
in - intraneuronal MAO activity following estradiol treatment. 
However, an opposite effect to the above finding was reported by 
urry et al., (1976) after a prolonged treatment of rats with 
high doses of estradiol. The contradiction here may relate to 
the different theshold doses for the inputs to the gland since 
various hormonal inputs affect pineal MAO activity. It seems 
therefore that estradiol manipulates pineal MAO activity in a 
dose-dependent, biphasic manner. 
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1.6.4.2 Effect of estradiol on pineal protein synthesis 
Cardinali et al., (1974) observed an increase in the 
incorporation of radiolabelled amino acids into pineal proteins 
following the injection of O,5-3,2~g of estradiol into 
ovariectomized rats. Estradiol (15nM) induced the synthesis of 
a specific protein in vitro. The properties of this protein 
were reported in uterus, adenohypophysis and hypothalamus 
(Mizobe and Kurokawa, 1977) . These effects of estradiol on 
protein synthesis required the integrity of the ganglionic 
sympathetic neurons since ganglionectomy but not ganglion 
decentralization, abolished them (Cardinali et al., 1976) . It 
also required continuous interaction of NE with B-adrenergic 
receptors, since administration of the B-blocker propranolol 
after estradiol administration impaired the ability of the 
hormone to increase total protein synthesis (Cardinali et al., 
1976). 
Clementi et al., (1965) reported histological changes indicating 
depressed pinealocyte function and reduced cytoplasmic RNA 
following estradiol administration. These authors observed a 
rise in protein synthesis in the pineal 24 hours after the 
steroid administration and also found that there were elevated 
levels of DNA and RNA in pineals 6 hours prior to the increase 
in protein synthesis. 
From these foregoing reports, estradiol does seem to positively 
influence pineal protein synthesis. 
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1.6.5 TESTOSTERONE [4-Androsten-17B-ol-3-one] 
Testosterone administration has influenced the following pineal 
metabolic activity and constituents: incorporation of labelled 
leucine into proteins (Cardinali et al., 1976, Nagle et al., 
1975), 5-HT content and turnover (Vacas and Cardinali, 1979), NE 
turnover rate (Cardinali et al., 1975), HIOMT activities (Nagle 
et al., 1974) and MAO activities (Urry et al., 1976). 
Cardinali et al., (1974 and 1975) have put forward postulations 
which lacked rigorous proof, on the presence of pineal receptors 
for testosterone. 
One important aspect of the physiological functions of 
testosterone in the pineal is its aromatization to estradiol. 
Some workers (Cardinali et al., 1974) believe this takes place 
prior to testosterone exerting its effect on pineal metabolic 
activities but this is discounted by other workers (Daya et al., 
1985). Evidence for the existence of a pineal site of action 
for androgens is overwhelming. Nagle et al., (1974) and 
Cardinali et al., (1974) found that pineals from castrated rats 
took up radiolabelled testosterone in vivo and in vitro up to a 
concentration about half that of the prostate . 
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1.6.5.1 Effect of testosterone on pineal enzymes 
1.6.5.1.1 HIOHT 
Houssay and Barce16 (1972) administered 30-100~gjday 
testosterone propionate (TP) for 21 days and found that HIOMT 
activity in castrated male rats was depressed. The findings by 
Nagle et al., (1974) that testosterone administered in doses of 
O,1-1,Omg per day for 3 days to castrated rats exerted an 
inductive effect on pineal HIOMT activity whilst pharmacological 
doses of 5mgjday depressed enzyme activity suggests that 
testosterone may apparently be exerting a dose-dependent 
biphasic effect of pineal HIOMT activity. simultaneous 
administration of NE reversed the stimulation of HIOMT brought 
about by TP, and potentiated its inhibition (Nagle et al., 
1974) . 
There are reports about the effect of other androgens on pineal 
HIOMT activity. Preslock, (1977) found that administration of 
androstenedione (100~gjday for 18 days) stimulated HIOMT 
activity in castrated cortunix quail. Benbelbaz-Vega, (1976) 
also reported that TP administration (10mgjday) depressed pineal 
HIOMT activity in penguins. 
1.6.5.1.2 SNAT 
Administration of TP or androstenedione at doses of 100mgjday 
for 18 days by Preslock, (1977) failed to influence pineal SNAT 
activity in castrated 
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cortunix quail. Testosterone 
administration to castrated male rats or ovariectomized female 
rats did not produce any significant effect on the 
responsiveness of pineal adenyl ate cyclase to NE (Weiss and 
Crayton, 1970). The findings of Pavlinov and Isachenhov (1979) 
following the administration of 50~g of various androgens to 
rats, 2 days after castration and 1 to 6 hours before sacrifice 
show that the nocturnal rise of pineal SNAT activity was 
stimulated in 2 to 4 hours. This finding was confirmed by 
Rudeen and Reiter (1977) who found that administration of 
subcutaneous pellet of 50~g TP brought about significant 
nocturnal elevation in pineal SNAT activity in castrated rats 
relative to approximately that of intact controls. 
1.6.5.2 Effect of testosterone on pineal protein synthesis 
Nagle et al., (1975) demonstrated that daily SUbcutaneous 
administration of TP to castrated rats brought about a 79% 
increase in pineal protein synthesis. Rats injected with a 
single dose of 500~g TP at the end of the dark period showed a 
150% increase of pineal protein synthesis whereas rats injected 
at the middle of the light period only showed 54% increase: 
maxima and minima of pineal testosterone uptake was observed at 
the same times, indicating that changes in the number of binding 
sites correlate with modification in the biological activity of 
the hormone in the pineal cells (Nagle et al., 1975). 
The testosterone-induced increase in pineal protein synthesis is 
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abolished by the administration of propranalol, a B-adrenergic 
blocker. This antagonistic effect of propranalol suggest two 
things: 
(i) the adrenergic blocker interrupts the interaction of the 
neurotransmitter with the cell membrane and thus impairs 
the effect mediated by an increased neural activity. 
(ii) continuous interaction of noradrenaline with postsynaptic 
receptors is required .for the pinealocytes to respond to 
increased intracellular levels of the gonadal hormone. 
1.6.6 PROGESTERONE [4-Pregnen-3,20-dione] 
The precise effect of progesterone on pineal metabolic 
activities have been in doubt for some time now. Neil and Smith 
(1974), in an assertion that has been widely accepted by many 
neuroendocrinologists, believed progesterone on its own is 
incapable in modifying neuroendocrine functions in 
oophorectomized rats unless estradiol is administered prior or 
following progesterone injection. Recent reports however 
indicate that progesterone on its own is able to modulate pineal 
biochemical functions without concomitant estradiol 
administration. However, firm conclusions with rigorous proof 
are hard to come by in view of the fact that the role of 
endogenous estradiol produced by the adrenal cortex has not been 
ruled out. At present, there are no reports on progesterone 
activity in ovariectomized-adrenalectomized rats. 
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1.6.6.1 Effect of progesterone on pineal enzymes 
1.6.6.1.1 HIOMT 
Houssay and Barce16 
stimulation of HIOMT 
(1972) reported 
activity. Yochim 
progesterone-induced 
and Wallen (1974) 
demonstrated that induction of pseudopregnancy (and thus of high 
circulating progesterone levels) caused significant changes of 
HIOMT rhythm in rats. Chronic progesterone administration to 
ovariectomized rats inhibited pineal HIOMT activity. This 
observed inhibition was contrary to the observation that in 
castrated cortunix quail, progesterone treatment restored 
depressed levels of pineal HIOMT activity. 
1.6.6.1.2 SKAT 
There is only one report in the literature on the effect of 
progesterone on SNAT activity. Pres lock (1977) found that in 
cortunix quail, pineal SNAT did not respond to progesterone 
treatment. 
1.6.6.2 Effect of progesterone on pineal protein synthesis 
cardinali and Vacas (1978b) demonstrated that there was a 
decrease in pineal protein synthesis following the 
administration of progesterone to ovariectomized rats. This was 
regardless whether or not estradiol was simultaneously 
administered. This may lend support to the observation that 
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estradiol does not mediate the effect of progesterone on pineal 
metabolic activities . Similarly, mediation by pituitary 
hormones on progesterone effects has been ruled out with the 
findings by Neil and smith (1974) that progesterone 
administration is unable itself to modify plasma gonadotropins 
on prolactin levels. progesterone appears to be acting directly 
on the pinealocytes. 
1.6 . 7 METnBOLISM OF SEX STEROIDS IN THE PINEAL GLAND 
1.6.7.1 Progesterone 
Hanukoghi et al., (1977); Luttge and Wallis (1973); Cardinali 
et al., (1975a) have independently demonstrated that 
progesterone is actively metabolized from the inCUbation medium 
by pineal tissue to 5a-reduced metabolites. Examples are 5a-
pregnanedione and 3a-hydroxy-5a-pregnan-20-one. 
The pineal gland from ovariectomized rats administered with 'H-
progesterone retained more unmetabolized progesterone than in 
any other CNS areas involved in neuroendocrine regulation. 
David et al . , (1975) also reported that some progestagens 
including norethynodral and 17a-hydroxyprogesterone were found 
to accumulate in the pineal gland of rhesus monkeys after 
intravenous or CSF administration . 
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Testosterone and estradiol 
Cardinali et al., (1974d) .reported identical radioactivity 
levels in the prostate and the pineal gland following the in 
vivo administration or in vitro incubation with 3H-testosterone. 
Cardinali et al., (1974d, 1974e) also reported that 3H-androgen 
metabolism by pineal cells involves 5a-reduction as well as 
aromatization to estrogens. The major metabolite is 5a-
dihydrotestosterone. Daya et al., (1985) have however shown 
that testosterone is able to exert its activity without prior 
conversion to estradiol. B-estradiol is methylated to the 3-
methylether of estradiol by partially purified bovine pineal 
HIOMT (Weiss et al., 1968). 
1.6.8 GONADAL SEX STEROID RECEPTORS IN THE PINEAL GLAND 
1.6.8.1 Estradiol receptors 
Marks et al., (1972) and Nagle et al., (1972) independently 
carried out studies to establish the presence of estradiol 
receptor on the pinealocytes. Nagle et al., (1973) reported 
that pineal explants obtained from ovariectomized rats took up 
and retained 3H-estradiol in vitro up to 35-fold the 
concentration in the incubation media and the analysis of 
cytosol fraction by Cardinali et al., (1975) for high affinity 
binding sites uncovered the presence of an estradiol-binding 
protein with Kd in the nanomolar range. 
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Cardinali et a1., (1975) further established that 3H-estradiol 
binding was displaced by excess estradiol, but not by 
testosterone, 5a-dihydrotestosterone (DHT) or progesterone and 
disappeared following incubation with trypsin or iodocetamide . 
The pineal estrogen binding protein content is significantly 
reduced by intraventricular administration of 6-hydroxydopamine 
and superior cervical ganglionectomy. Sympathetic innervation 
therefore influences the levels of estradiol binding protein. 
By inducing a specific high affinity binding sites in the pineal 
and uterus following the administration of 2IJg of estradiol 
benzoate for 3 days, Nagle et a1., (1973) found that in vitro 
uptake of 3H-estradio1 varied proportionally with the quantity 
of steroid in the medium. 
Reports by Notides and Gorski (1966); Katzenellebogen and Gorski 
(1972) as well as Mizobe and Kurokawa (1978) show that 
estradiol stimulates the formation of a protein species which 
resembles the estrogen-induced protein in rat uterus in its 
electrophoretic mobility. In the rhesus monkey, pineal 
estraphilic receptors have been characterized physicochemically 
and appear to be similar to those found in the rat brain (David 
et aI., 1975). 
The integrity of the sympathetic. input to the pineal gland is 
required for keeping appropriate levels of electrophilic 
receptors in the pineal gland (Cardinali et a1., 1975). The 
, 
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interaction of receptor-estradiol complex with nuclear acceptor 
sites is considered to be the initial step for hormone 
stimulation of nucleic acid and protein synthesis in the target 
tissues. By using the 3H-estradiol exchange assay to determine 
receptor hormone complexes in fractions of rat pineal homoge-
nates, the dissociation constant, dose-response and accumulation 
curves following estradiol treatment were found comparable to 
those of the hypothalamus and adenophysis (Cardinali, 1977). 
Autoradiographic analysis of rat pineal glands after in vivo 
administration of 3H-estradiol revealed nuclear concentrations 
of labelled grains in a still undefined population of cells 
(Stumpf et al., 1976), a finding compatible with the biochemical 
data on cytoplasmic and nuclear estraphilic receptors. Whether 
these cells are pinealocytes or glial cells, awaits further 
investigation (Vernadakis, 1978). 
1.6.8.2 Testosterone receptor 
Cardinali et al., (1976) and Nagle et al., (1975) demonstrated 
receptors for testosterone and DHT in the pineal gland. Prior 
to this, Cardinali et al., (1974c) have demonstrated the binding 
of androgens in the pineal to cytoplasmic proteins. Pineal 
glands from castrated rats take up radioactive testosterone in 
vivo and in vitro up to a concentration about half that of the 
prostate (Nagle et al., 1974; Cardinali et al., 1974), previous 
exposure to androgens in vivo significantly enhanced 3H_ 
testosterone uptake in vitro (Cardinali et al., 1974). 
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saturation analysis of testosterone and DHT binding sites in 
pineal cytosol indicated a K. in the nanomolar range (Cardinali 
et al., 1974), within the physiological concentrations of the 
hormone expected to reach the pineal from blood stream; binding 
was specific for androgens. 
Liao et al., (1972) reported that the 5a-androstanediol has a 
low affinity for the receptor similar to that observed in the 
prostate relative to testosterone and 5a-dihydrotestosterone 
which had a high affinity. The authors therefore postulated the 
following order of affinity of the steroids for pineal cytosol 
binding component: 5a-dihydrotestosterone > testosterone > 
androstenedione > estradiol > '5a-androstanedione > 5a-
androstanediol. 
'These data suggest the existence of a specific binding for 5a-
dihydrotestosterone in the nuclei of pineal cells. This is a 
similar situation to the prostate gland where 5a-
dihydrotestosterone rather than testosterone is bound to nuclear 
components. 
1.6.8.3 Progesterone receptors 
Luttge and Wallis (1972) reported the in vitro accumulation of 
3H-progesterone in several brain regions, the adenohypophysis, 
the pineal gland and the uterus of ovariectomized rats. 
Although the nature of radioactivity present in the tissue was 
not investigated, pineal 3H-progestin uptake was the highest 
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among the tissues studied. Vacas et al., (1979) reported that 
a cytosol progesterone receptor in the bovine pineal gland binds 
specifically with high affinity . In low ionic strength medium, 
this component exhibits a sediment coefficient similar to that 
described for the progesterone receptor in the uterus (Vu Hai 
and Milgrom, 1978), the hypothalamus (Kato and onuchi, 1977) and 
the adenohypophysis (Evans et al . , 1978; Kato and Onuchi, 1977). 
The pineal gland retains bound progesterone in preference to its 
5a-reduced metabolite (Karavolas et al., 1978). The peculiar 
binding characteristics of pineal progesterone-receptor 
complexes which explain the particular uptake and metabolism in 
the pineal gland has been reported (Vacas et al., 1979). 
Karavolas et al., (1978) suggested that the long retention of 
unmetabolized progesterone following its administration is a 
perculiarity of the pineal gland, not observed in hypothalamus, 
midbrain or pituitary. 
1.7 METABOLISM OF TRYPl'OPHAN AND THE KYlIURENINE HYPOTHESIS 
1.7.1 HEPATIC TRYPl'OPHAN PYRROLASE [L-TRYPl'OPHAN-OXYGEN 2,3-
OXIDOREDUCTASE, EC 1.13.11.11] 
1.7.1.1 Introduction 
Tryptophan pyrrolase is the haem-dependent liver cytosol enzyme 
that catalyses the oxidative cleavage of the pyrrole ring of L-
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tryptophan to produce N'-formylkynurenine during the initial and 
rate-limiting step of the kynurenine-nicotinic acid pathway of 
tryptophan degradation (Young et al., 1978: Young, 1981). 
In rat (Feigelson and Greengard, 1961) or human (Altman and 
Greengard, 1966) liver, but not in livers of certain animal 
species (Badawy and Evans, 1975), tryptophan pyrrolase exists in 
two forms. The already active holoenzyme does not require the 
addition of exogenous haematin for demonstration of its activity 
whereas the haem-free predominant form or apoenzyme does (Badawy 
and Evans, 1975). 
1.7.1.2 Regulation of Tryptophan pyrrolase Activity 
1.7.1.2.1 Activation of tryptophan pyrrolase 
The activation of the rat liver enzyme in vitro consists of two 
steps, both of which require the participation of tryptophan . 
The inactive apoenzyme is first conjugated with haem to form the 
oxidized (ferrihaem) holoenzyme (Fig.13). This is then reduced 
to the active form. Although, tryptophan can be replaced by 
some of its derivatives in the first step, its presence is 
obligatory for the reduction of the oxidized holoenzyme (Badawy, 
1979). 
Measurements of both apoenzyme and holoenzyme acti vi ties are 
important, not only to find out which formes) is inhibited or 
activated by a particular agent, but also to examine the 
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presence or absence of the enzyme. By performing such 
simultaneous measurements, it has been shown (Badawy and Evans, 
1976) that, although both forms are present in the liver of the 
chicken, mouse, pig, rat, turkey and possibly also man, the 
apoenzyme is absent from the cat, frog, gerbil, guinea pig, 
hamster, ox, rabbit and sheep. It is known that species lacking 
the apoenzyme also do not possess the hormonal induction 
mechanism and are sensitive to tryptophan toxicity because they 
metabolize the amino acid largely via the indoleamine routes 
(Badawy,1979). 
1.7.1.3 Hormonal and substrate mechanisms of tryptophan 
pyrrolase regulation 
By using the catalytic property of the rat liver enzyme, 
labelled amino acid incorporation into its purified protein and 
immunological-titration techniques, it has been possible clearly 
and conclusively to distinguish between these two mechanisms 
(Schimke et al., 1965; Knox, 1966; Schimke, 1969). The hormonal 
mechanism involves the induction of synthesis of the apoenzyme, 
probably by increasing the amount of the pyrrolase mRNA (DeLap 
and Feigelson, 1978), whereas the substrate mechanism consists 
of decreased degradation of pre-existing apo-(tryptophan 
pyrrolase) in the presence of the normal rate of synthesis. It 
has been suggested (Knox, 1966) that tryptophan stabilizes the 
enzyme causing an initial activation in vivo (Greengard and 
Feigelson, 1961; Badawy and Evans, 1975). This is unlikely 
because simple activation (by administration of haematin or its 
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precursor 5-aminolevulinate) does not stabilize the enzyme 
(Badawy and Evans, 1975). That stabilization requires the 
presence of tryptophan rather . than changes in pyrrolase activity 
is suggested by the finding (Badawy and Evans, 1975) that 
stabilization is achieved by a dose of tryptophan (50mg/kg) that 
does not enhance or activate the enzyme in fed rats, both under 
basal conditions and after hormonal induction or cofactor 
activation. 
1.7.1.4 Cofactor mechanism of tryptophan pyrrolase regulation 
The saturation of rat-liver apo-(tryptophan pyrrolase) with haem 
has been shown to be increased after administration of the haem 
precursor 5-aminolevulinate (Wetterberg et al., 1969; Druyan and 
Kelly, 1972; Badawy and Evans, 1973b) or haematin (Badawy and 
Evans, 1975) . These two agents therefore resemble tryptophan in 
activating the apoenzyme . They, however, do not stabilize the 
pyrrolase and this may explain why the overall enhancement of 
the enzyme activity by the cofactor mechanism is less strong 
than that achieved by tryptophan (Badawy, 1979) . 
1.7 . 1.5 Distribution of haem in the liver 
Liver haem is unequally distributed among mitodonchondrial 
cytochromes, microsomal cytochromes (cytochromes P-450 and b s ), 
catalase and cytosolic tryptophan pyrrolase . On the basis of 
the concentration of these haemoproteins, Marver and Schmid 
(1972) calculated that, of total liver haem, cytochrome P- 450, 
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catala~e and tryptophan pyrrolase utilize 66,16 and 1,4% 
respectively. The remainder of liver haem is used by the 
mitochondrial cytochromes, and since these have half-lives of 2 
days or longer, it may be suggested that they are unlikely to 
play an important role(s) in haem utilization under conditions 
involving rapid changes in haem metabolism . This suggestion is 
supported by the finding (Druyan and Kelly, 1972) that these 
cytochromes are not affected by the administration of the haem 
precursor 5-aminolevulinate or the porphyrogenic (porphyria-
producing) drug 2-allyl-2-isopropylacetamide (Badawy, 1989). 
1.7 . 1.6 Disorders of haem and porphyrin metabolism: the 
porphyrias 
The haem-biosynthetic pathway is normally controlled in such a 
manner that there is no excessive accumulation or excretion of 
intermediates of the pathway. The porphyrias are a group of 
conditions (hepatic and erythropoietic) in which the above 
control is lost and the excretion of porphyrins and their 
precursors is increased. These conditions affect almost all 
systems in the body, with abdominal pains and neurological 
disturbances being the most prominent symptoms. 
1.7.1.7 Regulation of haem biosynthesis and the concept of 
regulatory free-haem pool 
Haem is an important component of the functionally vital 
haemoproteins, and its regulation is therefore of considerable 
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importance to the functions and integrity of cells, tissues and 
the body as a whole (Badawy, 1979). 
It is now generally accepted that 5-aminolevulinate synthase is 
the point at which haem regulates its own synthesis by a 
negative feedback mechanism(s) in livers of chick embryos 
(Granick, 1966; Granick et al., 1975) and mammals (De Matteis, 
1975) including possibly man (Jeelani Dhar et aI., 1975). It 
follows therefore that haem could regulate its synthesis by a 
dual mechanism: the above negative one when liver haem 
concentration is increased, and a positive mechanism which 
involves the removal of the negative one secondary to decreased 
haem concentration. The mechanism(s) by which haem exerts the 
negative feedback control mentioned above is not fully 
understood at present. 
Current theories suggest an inhibition of transport of newly-
synthesized 5-aminolevulinate synthase from cytosol to 
mitochondria (in rat liver) (Hayashi -et al., 1972), repression 
of synthase synthesis (Granick et al., 1975) or inhibition of 
synthase activity (Tait, 1978). 
The ability of certain drugs to 
porphyria in mammals has played 
produce an experimental 
an important role in 
understanding the regulation of haem biosynthesis in the liver. 
The actions of drugs on mammalian liver 5-aminolevulinate 
synthase activity could be classified into two types. Firstly, 
a marked enhancement of synthase activity associated with an 
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accumulation of porphyrins in the 
administration of the porphyrogens 
allyl-2-isopropylacetamide, 
liver is produced after 
(porphyria-producing), 2-
3,5-diethoxcarbonyl-1,4-
dihydrocollidine and griseofulvin (De Matteis, 1967). By 
contrast, several lipid-soluble drugs (including phenobarbitone 
and phenylbutazone) cause a moderate stimulation of synthase 
activity and an increase in microsomal haem concentration, but 
not in that of porphyrins (De Matteis, 1973). When, however, 
one of the lipid-soluble drugs is administered together with a 
porphyrogen to intact animals (De Matteis and Gibbs, 1972; De 
Matteis, 1973) or to isolated perfused livers (Bock et al., 
1973), it potentiates the effects of the porphyrogen on synthase 
activity and porphyrin concentration, and De Matteis (1973, 
1975) suggested that this potentiation may explain the 
exacerbation of human hepatic porphyrias by drugs. 
The mechanism by which lipid-soluble drugs cause a moderate 
enhancement of synthase activity is not understood. 
Satyanarayana Rao et al., (1972) have shown that stabilization 
of synthase may be involved. By contrast, it is most likely 
that the masked enhancement of synthase activity by porphyrogens 
is produced by interference with the negative feedback mechanism 
involving the occurence of an early depletion of liver haem. It 
is therefore reasonable to suggest that this haem belongs to the 
so-called regulatory free-haem pool that has been suggested to 
be small and rapidly turning over (De Matteis, 1975; Granick et 
al . , 1975) . Since such a pool would be too small to be measured 
directly, the early depletion of haem has been demonstrated by 
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indirect methods involving the determination of activity or 
concentration of, or haem utilzation by, the hepatic 
haemoproteins catalase, cytochrome P-450 and tryptophan 
pyrrolase. There is considerable evidence (Badawy, 1978) 
implicating this early depletion of haem in the production of 
experimental porphyria. This concept in mammals does not apply 
to avian systems since several drugs known to cause an early 
depletion of liver haem in mammalian systems are capable of 
producing porphyria in avians (Granick, 1966; Creighton and 
Marks, 1972), and this has been suggested (De Matteis, 1973) to 
be due to the greater sensitivity of avian systems to drugs and 
also to the liability of their haem-biosynthetic pathway 
(Badawy, 1989). 
1.7.1.8 Comparison of haem utilization by liver haemoproteins 
1.7.1.8.1 The haem-saturation ratio 
with catalase and cytochrome P-450, the study of haem 
utilization is complicated by the fact that only the active 
(holoenzyme) forms can be measured, whereas both the active 
(holoenzyme) and inactive (apoenzyme) forms of tryptophan 
pyrrolase can be measured and altered both simultaneously and 
independently. Moreover, whereas the synthesis of apo-
(tryptophan pyrrolase) is not limited by decreased haem 
availability (Badawy and Evans, 1973b), that of apo-(cytochrome 
P-450) and apo-(catalase) is limited (Bhat et al., 1977; 
Yasukochi et al., 1974). These two points together with its 
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short half-life of 2,3h (Badawy and Evans, 1975) as compared to 
those of 7-10h and 24-48h for cytochrome P-450 (Marver and 
Schmid, 1972) and 29h or 2,5 days (Price et al., 1962; Yasukochi 
et al., 1974) for catalase, render apo-(tryptophan pyrrolase) a 
more suitable haemoprotein for assessing changes in liver haem 
concentration. 
This assessment is best expressed by the haem-saturation ratio . 
This is the ratio of holoenzyme/apoenz,yme activity, which 
indicates the extent of the haem saturation of the apoenzyme. 
The basal ratio (in fed rats) of < 1 is not altered after 
hormonal induction of the pyrrolase by cortisol administration 
or by the increased plasma corticosterone concentration during 
starvation (Badawy and Evans, 1973b; Badawy, 1977b). This is 
because the rise in the holoenzyme activity is matched by a 
proportionate increase in that of the total enzyme. This 
suggests that, under normal conditions of haem metabolism, the 
liver contains enough haem to saturate newly synthesized apo-
(tryptophan pyrrolase), a situation resembling that involving 
apd- (cytochrome P-450) induction by phenobarbitone and- other 
drugs (De Matteis, 1971), although the latter haemoprotein 
receives a much greater share of liver haem. 
1 . 7.1.8.2 Factors increasing the haem-saturation ratio 
The haem-saturation ratio of tryptophan pyrrolase is increased 
if only the holoenzyme activity is enhanced or if it is raised 
relati vely greater than that of the total enzyme. This is 
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achieved by treatments that increase the availability of haem by 
enhancing its utilization (e.g. phenobarbitone administered in 
drinking water 24 hrs previously) or its synthesis or 
concentration (1-2 hrs after administration of Al", 5- ALA, 
tryptophan or haematin) (Badawy and Evans, 1973a, b, 1975; 
Badawy,1977a). 
Bissell and Hammaker (1977) found that endotoxin administration 
increases the saturation of apo-(tryptophan pyrrolase) with haem 
by mechanism involving the dissociation of haem from apo-
(cytochrome P-450). with phenobarbitone, it is generally 
believed that its relatively late (12-24h after administration) 
effect on cytochrome P-450 is primarily due to the induction of 
• synthesis of the apoenzyme, al though there is evidence (De 
Matteis, 1975) that the drug enhances the utilization by 
cytochrome P-450 of haem newly synthesized from exogenous 
precursors and this has also been demonstrated with tryptophan 
pyrrolase in 5-aminolevulinate-treated rats (Badawy, 1977a). 
The effects of phenobarbitone on pyrrolase activity and haem 
utilization (Badawy and Evans 1973a, b; Badawy, 1977a), differ 
from those on cytochrome P-450 in several respects, the most 
important of which is that the drug-induced enhancement of haem 
utilization by tryptophan pyrrolase is pure phenomenon not 
associated with altered apoenzyme amounts. 
1.7.1.8.3 Factors decreasing the haem-saturation ratio 
The haem-saturation ratio of tryptophan pyrrolase is decreased 
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by treatments that limit the availability of haem by increasing 
destruction, inhibiting its synthesis or enhancing its 
degradation to bile pigments by stimulating haem oxygenase 
activity. Under these conditions, ' the ratio decreases if only 
the holoenzyme activity is decreased or that of the total enzyme 
is increased with the former remaining unaltered or being 
slightly enhanced. 
Acetate (inhibitor of the 5-ALA 
( inhibi tor of 5-ALA dehydratase 
synthase reaction), Pb2 • 
activity), porphyrogens 
(destroyers of haem and inhibitors of ferrochelatase activity) 
and substrates of glycine acyl transferase such as benzoate and 
p-aminobenzoate (diverting glycine away from the 5-ALA synthase 
step) cause an early decrease in the haem-saturation ratio, 
whereas metal cations (including Pb2.) produce a late decrease 
by stimulating haem oxygenase activity (Badawy and Evans, 1973b; 
Badawy, 1977a) . By contrast, catalase has only been reported to 
respond to the early depletion of haem by porphyrogens (De 
Matteis, 1978) and to the late one by Co2 • (Tephly et al . , 1973; 
Yasukochi et al., 1974) and by repeated administration of 
phenobarbitone plus the porphyrogen, 3,5-diethylcarbonyl-1,4-
dihydrocollidine (Sweeney, 1976). 
cytochrome P-450, on the other hand, responds to the late 
depletion of haem by metal cations and to the early one by 
porphyrogens administered alone (Piper and Tephly, 1974; De 
Matteis 1975; Maines and Kappas, 1976) . Moreover whereas early 
depletion of tryptophan pyrrolase haem caused by 3,5-
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diethoxycarbonyl-1,4-dihydrocollidine is potentiated by joint 
phenylbutazone administration (Badawy, 1976), that of cytochrome 
P-450 haem is not (De Matteis and Gibbs, 1972). 
1.7.1 . 8.4 Relationship between tryptophan pyrrolase and the 
regulatory free-haem pool 
It is suggested that the regulatory free-haem pool may be 
present in the cytosol since it is the only route for 
mitochondria-derived haem to the site(s) of 5-ALA synthase 
synthesis and/or repression (Yoda and Israels, 1972). The 
importance of the cytOSOl is further suggested by the finding in 
vitro (Yoda and Israels, 1972; Israels et al., 1975) that 
cytosolic proteins, with relatively low- and non-specif ic-
affinity sites for haem are required to contact the mitochondria 
to facilitate the exit of (newly synthesized) haem into the 
cytosol. 
It has been calculated (Badawy, 1978) that during the early 
depletion of pyrrolase haem by 3,5-diethoxycarbonyl-1,4-
dihydrocollidine plus phenylbutazone, there is a loss of O,093~M 
from the cytosol. This haem loss represents the largest 
depletion of pyrrolase haem under conditions of potentiated 
experimental porphyria, and is similar to the concentration 
(O,1~M) suggested by Granick et al., (1975) for free or readily 
exchangeable haem. It may therefore be suggested that the 
concentration of the regulatory free-haem pool is similar to, or 
lower than, the above value. Although, indirect, the above 
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calculations and the response of pyrrolase to changes in haem 
metabolism suggest that this enzyme may play an important role 
in the regulation of haem biosynthesis. 
1. 7.2 THE INDOLEAMIHE HYPOTHESIS 
The indoleamine hypothesis of depressive disorders is a 
variation of the catecholamine hypothesis, which states that 
depression is associated with a deficiency of brain serotonin 
(Lapin and Oxenkrug, 1969). Reserpine which depletes brain 
amines, frequently causes depression (Bunney and Davis, 1965) 
whereas monoamine oxidase (MAO) inhibitors which raise brain 
amine levels (Maclean et al., 1965) may alleviate depressive 
symptoms. The alleviation has been reported to be enhanced by 
tryptophan (copper et al., 1967), which is a precursor of the 
amines 5-HT and tryptamine. The apparent prophylaxis by 
tryptophan of an annual episode of depression has also been 
reported (Hertz and Sulman, 1968). These findings suggest an 
elevation of one or both of the above amines is responsible for 
the therapeutic effect of MAO inhibitors, and that their 
insufficiency may be responsible for symptoms of the disease. 
The effects of reserpine, MAO inhibitors and the tricyclic 
antidepressants on brain serotonin levels may be of major 
importance in the aetiology of depressive disorders. 
1.7.2.1 Implication of serotonin in depressive disorders 
( i) Depressed patients responding to MAO inhibitor drug 
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ipromazid were found in two studies (Pare and Sandler, 
1959; Praag and Leijnse , 1963), though not found in a 
third (Burgermeister et al., 1963) to have lower 
initial urinary excretion of the 5-HT metabolite 5-
HlAA than those who did not respond. 
( ii ) Depressed patients have a low content of 5-HlAA in the 
lumbar cerebrospinal fluid (Ashcroft et al., 1966) 
which rises on recovery. Although work using animals 
(Guldberg and Yates, 1968; Eccleston et al., 1968) 
shows that changes in brain 5-HT are paralleled by 
changes in brain 5-HlAA in the CSF, the significance 
of this result is not altogether clear, as lumbar 5-
HlAA depends not only on brain 5-HT metabolism but 
also on 5-HlAA transport within the CSF (Ashcroft et 
al . , 1966). Furthermore, a small group of acute 
schizophrenics on phenothiazines also had low 5-HlAA . 
(iii) There is some direct evidence of low 5-HT (Shaw et 
al., 1967) or 5-HlAA (Bourne et al . , 1968) in the 
hind-brains of depressive suicides. 
(iv) While single doses of 5-hydroxytryptophan, the 
immediate precursor of 5-HT do not alleviate 
depression, the remission of a prolonged episode of 
severe depression by administration of 5-
hydroxy tryptophan for five days have been reported 
(Persson and ROos, 1967). 
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Dewhurst (1968) found that tryptamine can influence mood but 
this effect is only potentiated by large amounts of tryptophan 
and MAO inhibitors (Eccleston et al., 1966). 
1.7.2.2 Implication of adrenocortical secretion in depression 
Abnormally high levels of adrenocortical secretion in the plasma 
of depressed patients has been reported (Gibbons and McHugh, 
1962; Hullin et al., 1967) although some workers (Sachar, 1967; 
Brooksbank and Coppen, 1967) consider this to be due to 
hospitalization or residual effects of previous stress, or to be 
in some way secondary to psychiatric symptoms. However, Bliss 
et al., (1967) reported that even in healthy subjects exposed to 
stress, there was an increase in adrenocortical secretion. The 
following points catalogue the implication of abnormal 
adrenocortical secretions in depressive disorders. 
(i) McClure, (1966), Bridges and Jones, (1966), Doig et 
al., (1966), Knapp et al (1967) all noted that there 
was elevated plasma corticoid levels in endogenous 
depression in early mornings a period of mood 
disturbances. The suggestion that barbiturates may 
cause the abnormal adrenocortical secretion (Sachar, 
1967) was discounted by Radzialowski and Bousquet 
(1968) who administered 100mg phenobarbitone per Kg 
per day for four days, and found no change in plasma 
corticosterone nor its rhythm in the rat. 
77 
(ii) Plasma corti co ids are high specifically in the 
depressed phase (Hullin et al . , 1967; Rubin, 1967; 
Rubin et al., 1968) in manic-depressive disease . 
(iii ) Depression is frequent in patients with a primary 
disturbance of pituitary-adrenal function (Trethowan 
and Cobb, 1952; Cleghorn, 1952) . 
( i v) Hydrocortisone secretion is not suppressed by 
dexamethasone in severe depression (Butler and Besser, 
1968); this indicates a lack of feedback inhibition 
of ACTH release which could be responsible for the 
high hydrocortisone secretion rate found (Gibbons, 
1962) • 
1.7.2.3 Tryptophan and depression 
There are reports that L-tryptophan is as effective as 
imipramine in the management of depression (Broadhurst, 1970; 
Coppen et al., 1967b) but there are serious doubts about this 
assertion since no placebo group was included and again since 
the study was not double-bl i nd. The apparant propylaxis by L-
tryptophan of an annual episode of depression has also been 
reported (Hertz and Sulman, 1968). 
Use of tryptophan pyrrolase inhibitors, such as allopurinol and 
nicotinamide, has been suggested as adjuncts in the treatment of 
depression (Curzon, 1969). These drugs would protect tryptophan 
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from excessive degradation along the irreversible pyrrolase-
catalysed oxidative kynurenine pathway and thus favour its 
passage to the brain where it can form serotonin. In a 
preliminary study, (Chouinard et al., 1977), nicotinamide has 
been used successfully in combination with L-tryptophan, all the 
depressed subjects showing significant improvement over a 4-week 
period. 
A study indicating L-tryptophan's ability to potentiate the 
antidepressive effects of a MAO inhibitor more positively 
connects indoleamines with depression. This potentiation was 
initially demonstrated by Copen et al., (1963) and has been 
confirmed by other workers (Pare, 1963; Glassman and Platman, 
1969; Van Praag, 1970). Van Praag (1962), however, had 
previously been unable to demonstrate this potentiation, either 
in terms of intensity or of rapidity of the antidepressant 
effect. Van Praag and Korf (1971a) explaining the variability 
of the reported resu1 ts, proposed that there is a serotonin 
deficient subgroup of depressed patients who respond to L-
tryptophan. The combination of L-tryptophan with clomipramine 
has also been reported to produce a more intensive antidepres-
sive effect than clomipramine alone (Walinder et al., 1975). 
1.7.2.4 Kynurenine Hypothesis 
Lapin and Oxenkrug, (1969); Curzon, (1969) and Curzon and 
Bridges, (1970) have proposed a link between defective 
metabolism and abnormally high adrenocortical secretion in some 
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groups of depressed patients. 
The mammalian body's supply of tryptophan is usually quite small 
(Fernstrom and Wurtman, 1974) since it is the least abundant of 
the essential amino acids in dietary protein. This brings to 
light the functional significance of tryptophan as a precursor 
of the neurotransmitter, serotonin. Several reports have 
detailed out the importance of changes in the availability of 
tryptophan in the regulation of serotonin synthesis in the brain 
(Fernstrom and Wurtman, 1971; Gessa and Tagliamonte, 1974; 
Hanson et al., 1974; Harper and Peters, 1989; Yokogoshi et al., 
1987). 
Tryptophan is known to be metabolized by several pathways. Less 
than 3% of dietary tryptophan is converted to serotonin and 
finally to 5-HlAA, its main excretion product (Fernstrom and 
wurtman, 1974). A quantitatively more important route involves 
the formation of nicotinic acid which is regulated by the liver 
enzyme, tryptophan pyrrolase, via the kynurenine intermediate. 
The activity of liver tryptophan pyrrolase has been reported to 
be increased by hydroxycorticosteroids (Knox 1951; Knox and 
Auerbach, 1955; Shan et al., 1968; Curzon, 1969; Young and 
Sourkes, 1977). This observation led to postulation of the 
hypothesis that the raised plasma cortisol levels seen in turn, 
may directly divert tryptophan away from serotonin formation 
(consequently reducing brain serotonin levels) and, instead 
increase metabolism along the tryptophan-nicotinic acid pathway 
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(Curzon, 1969; Curzon and Bridges, 1970). Thus depression is 
proposed to be associated with a decreased utilization of 
tryptophan in the formation of serotonin with a consequent 
increase utilization of tryptophan as a substrate for kynurenine 
formation. 
Determination of brain serotonin levels would give an idea ' about 
the relationship between pyrrolase activity and serotonin 
metabolism. There was a 30% reduction in rat brain serotonin 
levels (Curzon and Green, 1968) with a concomitant depression in 
5-HIAA levels following intraperitoneal administration of 5mg/Kg 
hydrocortisone. The same authors observed that tryptophan 
pyrrolase inhibitors (allopurinol and yohimbine) abolished 
hydrocortisone's effect on serotonin. Again, a-
methyl tryptophan, which causes pyrrolase activity to increase, 
also caused a reduction in brain serotonin levels. In other 
studies, female patients suffering from "endogenous" depression 
were found to excrete significantly greater amounts of 
kynurenine and 3-hydroxykynurenine than the female controls 
(Curzon and Bridges, 1970). 
Administration of kynurenine or other tryptophan metabolites 
formed subsequent to pyrrolase actions causes brain serotonin 
levels to fall (curzon and Green, 1968). 
Therefore increased formation of these substances due to 
increased pyrrolase activity may be involved in the mechanism by 
which brain serotonin levels decrease. 
81 
Lapin and Oxenkrug (1969) proposed that the depression of brain 
serotonin levels may result in weakening of the inhibitory 
processes on the amygdaloid complex (Fig.15). In man, 
activation of this area has been reported to increase plasma 
cortisol levels, presumably by stimulating the anterior 
pituitary to produce more ACTH. This brings about a vicious 
circle - low brain serotonin levels leading to activation of 
amygdaloid complex, . increased formation of hydrocorticosteroids 
and increased activity of tryptophan pyrrolase, which, in turn, 
would "shunt" the degradation of tryptophan away from serotonin 
to kynurenine (See Fig.16). 
If this hypothesis were true, it would be a matter of attacking 
the links in the chain in the treatment of depressive disorders. 
Serotonin precursors could be used in restoring serotonin brain 
levels. Drugs like imipramine or desipramine which inhibit 
tryptophan pyrrolase activity (Paracchi, 1967) following chronic 
administration therefore exert this action as a component of 
their antidepressive effect. Nicotinamide and allopurinol could 
be ·used in the treatment of depression (Curzon, 1969). These 
drugs would inhibit the degradation of tryptophan along the 
pyrrolase-catalyzed kynurenine pathway thereby increasing the 
formation of brain serotonin. Chouinard et a1., (1977) reported 
that the combination of L-tryptophan and nicotinamide has a 
cumulative antidepressive effect in some depressed subjects. 
At present, however, the kynurenine hypothesis remains 
speculative for the reasons discussed infra. 
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LOWERING OF INTENSITY ~<~ _____ _ 
OF SEROTONINERGIC , 
KYNURENINE PATHWAY 
(therefore decrease in 
brain serotonin levels) PROCESSES 
RELEASE OF AMYGDALOID 
INHIBITION ~ STIMULATION. OF TRYPTOPHAN 
PYRROLASE ACTIVITY 
INCREASED BLOOD· 
CORTICO~TEROID ~VELS 
Fig .15 • The Kynurenine Hypothesis and Sequence of Events 
Proposed by --Lapin and Oxenkrug (1969). 
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Increased synthesis 
wen SHT is 10"0( 
1------------7~------ '-~)s{IAA 
Tryptophan 
I 
Decreased synthesis 
wen pyrrolase is high 
Pyrrol"ase (increased ~Kynurenine etc. 
adrenocortical secretions) 
Fig. 16. Biochemical relatioships which may be involved in the regulation 
of tryptophan metabolism and may be relevant to the depressive 
illness. 
(Curzon, 1969) 
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(i) It is doubtful if the activation of tryptophan 
pyrrolase is sufficiently marked to draw a substantial 
amount of tryptophan away from serotonin synthesis. 
A drawing off of available tryptophan, however, seems 
unlikely since the pyrrolase pathway is only one of 
the important metabolic pathways of tryptophan. 
(ii) Van Praag (1977a) has reported a correlation between 
cortisol and plasma CSF tryptophan has not been 
studied in depressed patients. 
(iii) Normal CSF tryptophan levels have been reported in 
depressed patients (Ashcroft et al., 1973b). 
1.7 . 2.5 Effect of melatonin on the 5-ALA-induced rise of rat 
forebrain tryptophan and serotonin 
Badawy (1979) and other reports have documented the enhancement 
of the catabolic conversion of TRP to N'-formylkynurenine during 
the initial and rate limiting step of the kynurenine-nicotinic 
acid pathway of TRP degradation following activation of liver 
tryptophan pyrrolase by either haem or its precursor, 5-ALA. 
Daya et al., (1990) however found that if the forebrains of 5-
ALA-treated rats were collected after the onset of darkness, the 
levels of both TRP and 5-HT were significantly higher. This 
rise in brain indoles coincides with the natural rise in pineal 
and blood melatonin levels at night, (Reiter, 1988). In studies 
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undertaken by Daya et al., (1990) to find the link between these 
two observations, they demonstrated that melatonin 
administration to rats exposed to light brought about a reversal 
of the rise in forebrain TRP and 5-HT Melatonin also slightly 
suppressed forebrain TRP levels in non 5-ALA-treated rats . 
The results indicate that melatonin counteracts the 5-ALA-
induced rise of rat forebrain tryptophan and serotonin 
concentrations at night. 
1.7.2.6 Motivation For Research 
As referred to earlier, sex steroids are known to be associated 
with depression. Whether the sex steroids induce depression 
directly or by acting on liver tryptophan pyrrolase is not known 
since there are no reports in the literature on this topic . The 
purpose of the present study is to investigate whether a 
relationship exists between the sex steroids, l i ver tryptophan 
pyrrolase and brain indoleamines. 
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CHAPTER 2 
2.1 THE EFFECT OF GONADAL SEX STEROIDS ON HEPATIC TRYPTOPHAN 
PYRROLASE ACTIVITY 
2.1.1 
2.1.1.1 
EFFECT OF PARENTERAL ADMINISTRATION OF TESTOSTERONE, 
ESTRADIOL AND PROGESTERONE ON HEPATIC TRYPTOPHAN 
PYRROLASE ACTIVITY 
MATERIALS AND METHODS 
2.1.1.1.1 Chemicals 
The sex steroids, progesterone and B-estradiol-3-benzoate and 
the amino acid L-tryptophan were purchased from Sigma Chemical 
Company Mo, U. S. A. Testosterone was purchased from Merck, 
Germany. 
Sex steroids solutions in olive oil 
1m~/ml solutions of the 3 sex steroids were prepared in olive 
oil. 
O,03M L-tryptophan solution 
A 0, 03M solution of L-tryptophan was prepared by a slight 
modification of the method used by Badawy and Evans (1975). A 
total of 0, 612g of L-tryptophan was dissolved in a minimum 
volume of 2M NaOH and diluted to 40ml with 0,9% NaCI. The pH 
was then adjusted to 7,3 using 1M HCI. Finally, the solution 
was made up to 100ml with 0,9% NaCI . This was always prepared 
, 
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on the day of use. 
Sodium phosphate buffer pH 7,0 
Sodium phosphate buffer was prepared by dissolving 8g of NaOH 
and 24g of NaH2PO, separately in 11 of solution and then mixing 
300ml and 500ml respectively of the NaOH and NaH2PO, solution to 
give the final buffer of pH 7,0. 
HOlllOgenizinq mixture 
The homogenizing mixture was prepared by mixing 1,043g KCl and 
O,lg NaOH in 100m] of solution. This was always kept ice-cold. 
2.1.1.1.2 Animals 
Inbred albino Wi star male and female rats were used. The rats 
which weighed between 200g and 300g were maintained on Epol Rat 
food and water a~ libitum. The rats were housed in groups of 6 
in plastic cages and kept in an animal room, with temperature at 
about 20'C and with an automatically regulated lighting system 
maintaining a 12 hours light/12 hours dark cycle. 
2.r.1.1.3 Adainistration of steroids 
2 groups of male rats (6 in each group) were subcutaneously 
injected with O,lml of testosterone (Test Rats) and olive oil 
(Control Rats) respectively. The animals were injected twice 
daily at 09hOO and 15hOO for 5 days. Female rats (6 in each 
test group) were similarly dosed with O,lml of progesterone and 
a,lml estradiol. Control rats received doses of olive oil. 
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2.1.1.2 Determination of Tryptophan Pyrrolase Activity 
In the rat liver, circulating tryptophan is degraded through a 
series of metabolic processes to nicotinic acid. The initial 
and rate-limiting step of that pathway is the conversion of L-
tryptophan to N'-formylkynurenine. This step is catalysed by 
the haem-dependent oxidoreductase, tryptophan pyrrolase. 
The acti vi ty of the enzyme was determined by measuring the 
formation of kynurenine from L-tryptophan (Feigelson and 
Greengard, 1961). 
The rats were sacrificed a day after the last steroid 
administration. The liver was removed within 30s and then 
homogenized at 1 100 rev/min in 6,5 volume of 140rnM KCI - 2,5rnM 
NaOH homogenizing mixture at O°C for 1 minute. The liver 
homogenate was homogenized again, this time using a Wheaton 
dounce homogenizer with a loose-fitting Teflon pestle. 15ml 
samples of the liver homogenate were added to a solution made up 
of 5ml of 0, 03M L-tryptophan, 15ml of 0, 2M sodium phosphate 
buffer pH 7,0 and 25ml of distilled water at O°C. 
3ml samples of the assay mixture were incubated at 37°C for 0, 
15, 30, 45, 60, 75, 90, 105 minutes with shaking (120 
oscillations/min) in stoppered boiling tubes in an atmosphere of 
95% O2 and 5% CO2 • The reaction was stopped at each of the above 
time-intervals by the addition of 2ml of 0,9M trichloroacetic 
acid. The flasks and contents were shaken for a further 2 
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minutes and then filtered on Whatman No.1 filter paper. To 
2,5ml of the ' filtrate, 1,5ml of 0,6M NaOH was added and the 
kynurenine present was determined by measuring the absorbance on 
a Bausch and Lomb Spectronic 301. 
The activity of tryptophan pyrrolase was calculated from the 
increase in E3 •• with time during the linear phase. Using a 
combination of Beer's and Lambert's Laws, A = Ecl with E = 4 
540 litre/mol.cm, the amount of kynurenine formed at the end of 
each time interval was quantitatively determined. Tryptophan 
pyrrolase activity was expressed in terms of the amount of 
kynurenine formed in ~mole/gram wet weight of liver. 
Liver tryptophan pyrrolase exists in two forms (Badawy and 
Evans, 1974). The already active holoenzyme does not require 
the addition of exogenous haematin for demonstration of its 
activity in vitro (Feigelson and Greengard, 1961), whereas the 
haem-free predominant form or the apoenzyme does. 
The activity of tryptophan pyrrolase determined in the various 
experiments therefore applies to the holoenzyme form of the 
enzyme, since nei ther haematin nor its precursor 5-
aminolevulinic acid was administered to stimulate the apoenzyme. 
In the initial and trial run for tryptophan pyrrolase assay, an 
attempt was made to determine to what degree freezing the liver 
would have on the activity of the enzyme. The need for this 
arose out of concern from Badawy's (1974) observation that 
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guinea-pig liver tryptophan pyrrolase when assayed in fresh 
homogenates, exists only as the holoenzyme. It does not respond 
to agents that activate or inhibit rat liver enzyme in vitro 
Only by aging (for 30 min at 5°C) does the guinea-pig liver 
enzyme develop a requirement for activators or inhibitors . 
Tryptophan pyrrolase activity was assayed firstly from livers 
which have been previously frozen under cryonic (-70°C) 
conditions and secondly from fresh liver homogenates. The 
results from the frozen livers were conflicting but those from 
the fresh homogenates were consistent and reproducible. From 
then on, only fresh livers were used for enzyme assays. 
2.1.1.3 Results 
All data are expressed as the mean ± standard error of the mean. 
The data were analysed by one-way analysis of variance and the 
statistical significance among the means was determined using 
the Student-Newman-Keul' s Test for 3 or more groups and the 
student t test for 2 groups. A P value of less than 0,05 was 
considered statistically significant . 
2.1.2 
2.1.2.1 
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EFFECT OF TESTOSTERONE ADMINISTRATION ON TRYPTOPHAN 
PYRROLASE ACTIVITY 
Materials and Methods 
Male rats weighing between 200g and 300g were used. 2 groups of 
6 rats each were housed in plastic cages. The first group of 6 
rats (Test group) were subcutaneously injected with O,lml of 
testosterone solution in olive oil. The injections were carried 
out twice daily (09hOO and 15hOO) for 5 days . The second group 
(Control group) were similarly injected with the vehicle i . e. 
olive oil. The rats were sacrificed on the 6th day, the livers 
rapidly removed, homogenized and the activity of liver 
tryptophan pyrrolase assayed as described earlier (2 . 1.1 . 2). 
2.1.2 . 2 Results 
As shown in Table 1 and Fig.17. 
From the results, it is evident that for all the time intervals, 
there was a significant increase in the activity of tryptophan 
pyrrolase in the livers of the test animals which were dosed 
with the steroid relative to the controls. 
2.1.2.3 Discussion 
At present, there are no literature reports on the precise 
effect of the gonadal sex steroids on hepatic tryptophan 
pyrrolase activity. It has however been well documented that 
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tryptophan pyrrolase, the enzyme which catalyses the initial and 
rate determining step of the oxidative Kynurenine-Nicotinic acid 
pathway, is dependent on the availability of its haem cofactor, 
(Bender 1975). Badawy (1987) has shown that when the enzyme is 
saturated with haem by the administration of the haem precursor 
5-aminolevulinic acid (5-ALA) the activity of the enzyme is 
increased. This brings about increased catabolism of 
circulating tryptophan and as a consequence reduces tryptophan 
concentrations for uptake by the brain and thereby reducing 
brain serotonin levels (Badawy et al., 1987; Oaya et al., 
1989). Lapin and Oxenkrug (1969) formulated the indolamine 
theory of affective disorders which associated the deficiency of 
functionally active serotonin, a neurotransmitter in the brain 
with depression. The implication here is an agent which raises 
the level of activity of tryptophan pryrrolase invariably brings 
about depression. A lot of clinical studies obviously have to 
be carried out in order to draw the salient link between the sex 
steroids and depression. Given its strong inductive effect on 
liver tryptophan pyrrolase, testosterone, if present in 
concentrations above physiological concentrations may bring 
about reduced levels of circulating tryptophan. 
INCUBATION TIME 
INTERVAL (MIN) 
BLANK 
15 
30 
45 
60 
75 
90 
105 
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KYNURENINE CONC. 
in j.lmole/g wet 
weight of liver 
± S.E.M. 
TEST CONTROL 
RATS RATS 
0,00 0,00 
1,74 ± 0,11 1,64 ± 0,10 
3,95 ± 0,28 3,27 ± 0,27 
6,89 ± 0,48 4,73 ± 0,35 
9,23 ± 0,51 6,73 ± 0,43 
11,05 ± 0,60 7,82 ± 0,57 
13,61 ± 0,69 8,73 ± 0,60 
14.98 ± 0,73 9,49 + 0,61 
SIGNIFICANCE 
students 
t test 
N. S. 
N. S. 
p < 0,05 
p < 0,05 
p < 0,05 
p < 0,05 
P < 0,05 
TABLE 1. effect of testosterone administration on hepatic 
tryptophan pyrrolase activity . Test rats were 
injected twice daily for 5 days. They were sacrificed 
on the 6th day . (n = 5). Control rats were dosed with 
the vehicle. Concentration of testosterone was 
1mg/ml. 
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fig . 17. effect of testosterone administration on hepat ic tryptophan pyr-
rolase activity 
• NoS. : p < 0.05 
2.1.3 
2.1.3.1 
95 
EFFECT OF PROGESTERONE ADMINISTRAITON ON TRYPTOPHAN 
PYRROLASE ACTIVITY 
Materials and Methods 
Female rats weighing between 200g and 250g were used for this 
study. O,lml of Img/ml progesterone solution in olive oil was 
subcutaneously administered to 6 rats, twice daily for 5 days. 
The second group of 6 rats were similarly injected with the 
vehicle. The rats were sacrificed on the 6th day, the livers 
rapidly removed, homogenized and the activity of liver 
tryptophan pyrrolase assayed as described previously (2 . 1.1.2). 
2.1.3.2 Results 
As shown in Table 2 and Fig . 1B. 
Progesterone administration brought about a significant increase 
in the activity of tryptophan pyrrolase. 
2.1 . 3.3 Discussion 
Progesterone was found to have a positive inductive effect on 
the activity of hepatic tryptophan pyrrolase. 
INCUBATION TIME 
INTERVAL (MIN) 
BLANK 
15 
30 
45 
60 
75 
90 
105 
96 
KYNURENINE CONC. 
in I-'mole/g wet 
weight of liver 
± S.E.M. 
TEST CONTROL 
RATS RATS 
0,00 0,00 
1,61 ± 0,15 1,53 ± 0,17 
4,73 ± 0,30 4,97 ± 0,19 
6,81 ± 0,31 4,20 ± 0,32 
8,84 ± 0,45 6,50 ± 0,51 
11,12 ± 0,59 6,95 ± 0,58 
13,07 ± 0,65 7,98 ± 0,61 
15.71 + 0.73 10.20 ± 0.68 
SIGNIFICANCE 
students 
t test 
N. S. 
N.S. 
P < 0,05 
P < 0,05 
P < 0,05 
P < 0,05 
P < 0 . 05 
TABLE 2. effect of progesterone administration on hepatic 
tryptophan pyrrolase activity. Test rats were 
injected twice daily for 5 days. They were sacrificed 
on the 6th day. (n = 5). Control rats were injected 
with the vehicle. 
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2.1 . 4.1 
98 
EFFECT OF ESTRADIOL ADMINISTRATION ON TRYPTOPHAN 
PYRROLASE ACTIVITY 
Materials and Methods 
Female rats weighing between 200g and 250g were used for this 
study. o,lml of 1mg/ml B-estradiol-3-benzoate solution in olive 
oil was subcutaneously administered to 6 rats, twice daily for 
5 days. The second group of 6 rats were similarly injected with 
the vehicle. The rats were sacrificed on the 6th day. The 
livers were rapidly removed, homogenized and the activity of 
liver tryptophan pyrrolase assayed as described earlier 
(2.1.1.2). 
2.1.4.2 Results 
As shown in Table 3 and Fig.19. 
B-estradiol-3-benzoate was found to have a pattern of induction 
of tryptophan pyrrolase similar to testosterone and 
progesterone. 
2.1.4.3 Discussion 
Estradiol in high concentrations may also reduce circulating 
levels of tryptophan . 
I 
I 
I 
I 
l 
INCUBATION TIME 
INTERVAL (MIN) 
BLANK 
15 
30 
45 
60 
75 
90 
105 
99 
KYNURENINE CONC. 
in ~mole/g wet 
weight of liver 
± S.E.M . 
TEST CONTROL 
RATS RATS 
0,00 000 
1,17 ± 0,11 1,23 ± 0,09 
3,10 ± 0,12 3,12 ± 0,11 
5,13 ± 0,38 3,89 ± 0,24 
7,98 ± 0,60 4,33 ± 0,38 
9,87 ± 0,70 5,11 ± 0,45 
11,81 ± 0,78 6,05 ± 0,51 
13.27 + 0.83 7.13 + 0.67 
SIGNIFICANCE 
students 
t test 
N.S. 
N.S. 
P < 0,05 
P < 0,05 
P < 0,05 
p < 0,05 
P < 0.05 
TABLE 3. effect of estradiol administration on hepatic 
tryptophan pyrrolase activity. Test rats were 
injected twice daily for 5 days. They were sacrificed 
on the 6th day. (n = 5). Control rats were injected 
with olive oil. 
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2.2 EFFECT OF TRYPTOPHAN PYRROLASE CONCENTRATION ON KYNURENINE 
PRODUCTION 
2.2.1 MATERIALS AND METHODS 
5 male rats weighing 200-300g were used. The rats were 
exsanguinated and the livers rapidly removed and weighed. The 
liver was homogenized in 7 vol alkaline KCl on a mechanical 
homogenizer at 1 100 rev/min for 2 minutes. Table 4 shows the 
various volumes of buffer, water, tryptophan solution and liver 
homogenate that were mixed to give a resulting solution that was 
incubated at 37°C in boiling tubes in an atmosphere of carbogen. 
The assay mixture was incubated for 60 minutes with oscillations 
(120/min). The reaction was stopped by the addition of 15% 
metaphosphoric acid. The assay mixture was then shaken for 5 
minutes after which it was filtered. A 3,Oml aliquot of the 
filtrate was neutralized by 1ml of 1NNaOH solution. The 
absorbance was then read at 365nm on a Bausch and Lomb 
Spectronic 301. 
2.2.2 RESULTS 
Table 5 gives the kynurenine concentrations for the various 
concentrations of the enzyme. Kynurenine concentrations 
increased with increasing concentrations of the enzyme . The 
amount of kynurenine formed for each assay mixture was 
quantitatively determined by the application of Beer-Lambert 
Law. The molar extinction coefficient for kynurenine at 365 nm 
and between pH 6,5 to 7,5 is 4,53 x 10'. 
Vol. of 
Buffer 
(mIl 
1 
1 
1 
1 
1 
1 
TABLE 4. 
Vol. of 
Buffer 
(ml 1 
1 
1 
1 
1 
1 
1 
Vo1.of 
Water 
(mIl 
0,7 
1,7 
2,0 
2,2 
2,4 
2.6 
102 
Vol. of 
Tryptophan 
so In (ml 1 
0,3 
0,3 
0,3 
0,3 
0,3 
0.3 
Vol. of liver 
homogenate 
(ml 1 
2 
1 
0,7 
0,5 
0,3 
0.1 
preparation of assay mixture 
determination of kynurenine 
concentrations. 
for the quanti tati ve 
at various enzyme 
Vol. of 
Water 
(ml 1 
0,7 
1,7 
2,0 
2,2 
2,4 
2.6 
Vol. of 
Tryptophan 
soln (mIl 
0,3 
0,3 
0,3 
0,3 
0,3 
0.3 
Vol. of liver 
homogenate 
(mIl 
2 
1 
0,7 
0,5 
0,3 
0.1 
Kynurenine 
concentration 
in ~mole/g wet 
weight of liver 
7,8 
4,0 
3,6 
3,0 
2,5 
2.0 
TABLE 5. quantitative determination of kynurenine production 
with increasing enzyme concentrations. 
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Fig . 20 . ef fect of tryptophan pyrrolase concentration on kynurenine pro-
duction 
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2.3 EFFECT OF ORCHIDECTOMY ON HEPATIC TRYPTOPHAN PYRROLASE 
ACTIVITY 
2 . 3.1 ANIMALS 
Male albino rats of the Wistar strain weighing 200-300g were 
used for this study. The animals were housed under conditions 
described earlier. 
2.3.1.1 surgery 
The surgical procedure used in this study was essentially that 
used by Oaya (MSc dissertation, 1982) and is described infra. 
2.3.1.1.1 Anaesthesia 
The rat was placed in a dessicator with cotton wool soaked in 
diethyl ether as the anaesthetic. It was taken out of the 
dessicator and placed on the operating surface. A 150ml conical 
flask containing cotton wool soaked in ether was placed about 
2cm in front of the rat's nose, with the open mouth of the 
conical flask directly facing the rat's nose. The surgery was 
then performed. The rat's respiration was closely monitored 
during surgery. 
flask was moved 
If the breathing became too weak, the conical 
further away from the rat's nose to help 
recovery. The colour of the limbs and the tip of the tail gave 
a good indication of the depth of anaesthesia. A faint pinkness 
of the limbs and tail was observed during the optimum level of 
105 
anaesthesia, optimum in this case meaning a good rate and depth 
of respiration with a good narcosis. A purple colour was 
indicative of cyanosis. This method of anaesthesia proved to be 
successful with a high survival rate and lack of complications. 
The rats normally recovered consciousness in about 10 minutes 
after surgery. 
2.3.1.1.2 Bilateral Orchidectomy (Castration) 
Male rats under anaesthesia were placed in the spread-eagle 
position and the area around the scrotal sac was moistened with 
saline. The hair on and around the scrotal sac was shaved. 
The shaved area was swabbed with an iodine solution in ethanol. 
A longitudinal incision about 1cm long was made along the centre 
line on the scrotal sac to expose the testes. The testes were 
drawn through the incision by pulling the cauda epididymis with 
forceps. The testicular blood vessels, vas deferens and 
spermatic ducts were ligatured distal to the caput epididymis 
and the testes were excised. The incision was stitched and the 
rat was allowed to recover. 
2.3 . 1.1.3 Sham-operations 
Sham-operations were carried out on the rats for this study and 
all studies in this dissertation which involved orchidectomy and 
ovariectomy. The rats used for sham operations went through 
identical anaesthesia and surgical procedures as those in the 
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test group except that neither the ovaries nor testes were 
excised . Unless otherwise stated, all rats which served as 
controls for orchidectomy and ovariectomy studies were sham-
operated. 
2.3 . 2 MATERIALS AND METHODS 
A total of 15 male rats weighing 200g-300g, 10 of which had been 
castrated two weeks earlier were used for this study. The 10 
castrated rats were divided into 2 groups of 5 rats each . The 
first group was subcutaneously dosed with 0 , 1ml of 1mg/ml 
testosterone solution, twi ce daily for 5 days. The second group 
of castrated rats and the 5 intact rats were subcutaneously 
injected with the vehicle. The rats were sacrificed by stunning 
and neck fracture on the 6th day after the injections started. 
The liver was rapidly removed, homogenized and activity of the 
tryptophan pyrrolase was assayed as described earlier (2.1.1 . 2) . 
2.3.3 RESULTS 
As shown in Table 6 and Fig.21. 
The activity of tryptophan pyrrolase was highest in the livers 
of castrated rats which were dosed with testosterone . The 
enzyme activity was relatively lower in the livers of intact 
rats. The lowest enzyme activity was found in the livers of 
castrated rats. For most of the time intervals, the differences 
between the 3 groups of rats were statistically significant. 
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2.3.4 DISCUSSION 
The activity of tryptophan pyrrolase was highest in the livers 
of castrated rats dosed with testosterone. The activity of the 
enzyme in the intact livers was relatively lower. The lowest 
enzyme acti vi ty was in the livers of castrated rats . This 
observation reinforces the earlier finding (see 2.1.2.3) that 
testosterone induces tryptophan pyrrolase activity. 
By removing the testes of the animals by way of orchidectomy 
implies the removal of the source of production of testosterone 
in the body of the animal. A direct consequence of this would 
be the removal of the inductive effect of testosterone on 
tryptophan pyrrolase activity. The lowest activity of 
tryptophan pyrrolase observed 
therefore in conformity with 
in the castrated 
this. The intact 
rats 
rats 
was 
had 
circulating testosterone in their bodies which induced 
tryptophan pyrrolase activity but this activity was still lower 
than that of the castrated rats which were treated with 
testosterone. A possible explanation here is that the 
testosterone administered to the castrated rats were in 
concentrations far higher than physiological concentrations and 
this resulted in the highest hepatic tryptophan pyrrolase 
activity in this particular group. 
INCUBATION 
TIME INTER-
VAL (MIN) 
BLANK 
15 
30 
45 
60 
75 
90 
105 
Castrated 
rats dosed 
with 
testosterone 
(A) 
0,00 
2,13 ± 0,10 
3,56 ± 0,20 
6,B2 ± O,B3 
B,70 ± 0,95 
11,03 ± 1,1 
14,57 ± 1,5 
17.15 + 1.B 
lOB 
KYNURENINE CONC. SIGNIFICANCE 
in I'molejg wet 
weight of liver A compared 
± S.E.M. to Band C 
Castrated Intact 
rats rats S-N-K test 
(B) (C) 
0,00 0,00 
l,B5 ± 0,09 1,90 ± 0,15 N.S. 
1,90 ± 0,11 3,11 ± 0,20 N. S. 
2,31 ± 0,13 4,35 ± O,3B p < 0,05 
2,BO ± 0,16 5,BO ± 0,50 p < 0,05 
3,50 ± 0,19 7,13 ± 0,90 p < 0,05 
4,30 ± 0,30 9,73 ± 0,96 p < 0,05 
6.BO + 0.5 11.05 + 1.3 P < 0.05 
TABLE 6. effect of castration and testosterone administration 
on tryptophan pyrrolase activity. A group of 
castrated rats were dosed with 1mgjml testosterone 
twice daily for 5 days. A second group of castrated 
rats as well as the third group of intact rats were 
similarly dosed with the vehicle. All the rats were 
sacrificed on the 6th day. 
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2.4 EFFECT OF OVARIECTOMY ON HEPATIC TRYPTOPHAN PYRROLASE 
ACTIVITY 
2.4.1 ANIMALS 
Female albino rats of the wi star strain weighing 200-250g were 
used for this study. The rats were housed under conditions 
described earlier. 
2.4.1.1 Surgery 
2.4.1.1.1 Anaesthesia 
The animals were anaesthesized according to the procedures 
previously described (2.3.1.1.1). 
2.4.1.1.2 Bilateral ovariectomy 
After the application of anaesthesia, the rats were placed on 
their sides on the operating surface and the area of the abdomen 
on the side, just above the thigh was moistened with saline 
solution. The hair in this region was cut to expose the skin . 
The skin was swabbed with a solution of iodine and a lcm 
incision was made through the skin exposing the abdominal 
muscles. An incision was made through the muscles and abdominal 
wall. The fat surrounding the ovary was immediately visible as 
it lay just beneath the incision. Using forceps, the fat with 
the ovary was pulled carefully through the incision. The 
III 
ovarian artery, vein and part of the uterine horn were ligatured 
and the ovary was excised. The incisions were stitched with 
suture under aseptic conditions. The rat was then turned to the 
other side and the same procedure was applied to remove the 
other ovary. The rat was finally allowed to regain 
consciousness. 
2.4.2 MATERIALS AND METHODS 
A total of 15 female rats, 10 of which had been ovariectomized 
two weeks earlier were used for this study. The 10 
ovariectomized rats were divided into 2 groups of 5 rats each. 
D,lml of Img/ml progesterone solution was subcutaneously 
administered to the first group twice daily for 5 days. The 
second group of ovariectomized rats and the 5 intact rats were 
subcutaneously dosed with the vehicle at the same frequency and 
for the same number of days. The rats were sacrificed on the 
6th day. The livers were rapidly removed, homogenized and the 
activity of tryptophan pyrrolase was assayed as outlined 
previously (2.1.1.2). 
2.4.3 RESULTS 
As shown in Table 7 and Fig.22. 
The effect of ovariectomy and progesterone administration on 
tryptophan pyrrolase acti vi ty was identical to the pattern 
observed with castration and testosterone administration to male 
rats. The livers of ovariectomized rats dosed with progesterone 
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exhibited the highest enzyme a c tivity. The enzyme activity was 
relatively lower in the livers of the intact rats. The lowest 
enzyme activity was observed in the livers of ovariectomized 
rats. The differences between the various experimental groups 
were statistically significant. 
2 . 4.4 DISCUSSION 
Presently, there are no literature reports on the effect of 
ovariectomy and progesterone administration on hepatic 
tryptophan pyrrolase activity. A possible explanation however 
of the elevated activity of tryptophan pyrrolase in the livers 
of ovariectomi zed rats, dosed with progesterone is that the 
progesterone administered might be in concentrations higher than 
physiological i.e. pharmacological. As a result, there would be 
a strong inductive effect on the activity of the enzyme. The 
lower enzyme activity in the livers of ovariectomized rats 
relative to the intact livers is understandable in the light of 
the fact that the intact rats still have an appreciable level of 
circulating sex hormones whilst the ovariectomized rats 
practically have none . This observation on the effect of 
progesterone on tryptophan pyrrolase actvitiy is consistent with 
an earlier observation (see 2.1 . 3 . 3). 
INCUBATION 
TIME INTER-
VAL (MIN) 
BLANK 
15 
30 
45 
60 
75 
90 
105 
113 
KYNURENINE CONC . 
in /Jmole/g wet 
weight of liver 
± S.E.M. 
Ovariec- Ovariec-
tomised rats tomised 
dosed with rats 
testosterone 
CAl C B 1 
0,00 0,00 
1,70 ± 0,15 1,30 ± 0,09 
3,85 ± 0,15 3,40 ± 0,23 
8,01 ± 0,9 4,47 ± 0,31 
10,59 ± 1,0 5,01 ± 0,36 
13,07 ± 1,1 5,83 ± 0,40 
15,37 ± 1,2 6,30 ± 0,50 
17.89 + 1.4 7.53 + 0,67 
SIGNIFICANCE 
A compared 
to B and C 
Intact 
rats S-N-K test 
CCl 
0,00 
1,04 ± 0,10 N.S. 
3,67 ± 0,25 N. S . 
5,36 ± 0,38 p < 0,05 
6,13 ± 0,47 p < 0,05 
8,52 ± 0,75 p < 0,05 
10,61 ± 0 , 90 p < 0,05 
12.03 + 1.10 P < 0.05 
TABLE 7. effect of ovariectomy and progesterone administration 
on tryptophan pyrrolase acti vi ty . The first group of 
ovariectomized rats were injected with progesterone 
twice daily for 5 days. The second group of 
ovariectomized rats as well as the third group of 
intact rats were similarly injected with olive oil. 
All the rats were sacrificed on the 6th day. 
" " > 
.... 
.... 
'" 0 
" .<: 
'" 
. ., 
" :. 
" 
" :. 
'" ..... 
" .... 
0 
e 
"-
(J 
" 0 (J 
" " .... 
" 
" 
" :I ~ 
'" 
18 
15 
14 
12 
10 
114 
.. I···························· ... .......................................... . 
15 45 
• 
• 
• 
• 
75 
• 
• 
105 
Incubation time interval (min) 
~ 
A 
-B 
c 
Fig. 22. effect of ovariectomy and progesterone administration on hepatic 
tryptophan pyrrolase activity 
A. ovariectomized rats were injected with progesteror.e twice dai-
ly for five days 
B. 
C. 
ovariectomized rats were injected with the vehicle 
intact rats were injected with the vehicle 
A compared to 8 and C • N. S. : p < 0.05 
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CHAPTER 3 
3.1 ORGAN CULTURE EXPERIMENTS AND SCINTILLOMETRY 
Introduction 
strangeways (Strangeways and Fell, 1926) became a pioneer in the 
use of organ culture when he employed the technique to culture 
embryonic organ rudiments. The procedure affords the worker the 
useful advantage of monitori ng the effects of drugs on an organ 
consti tuent without the complications of organ interactions . 
Trowell (1959), modified the apparatus and techniques for organ 
culture so as to keep a number of fully differentiated organs 
alive in vitro, without either growth or differentiation, thus 
opening the way for many experimental studies (Daya, 1982). 
Scintillometry is a very effective technique used in the study 
of radioisotopic compounds that emit B-particles . The light-
emitting process during scintillation counting of B-particle 
emissions occurs as a result of a radioactive sample bei ng 
placed in a "scintillation cocktail" containing an excitable 
solvent and one or more fluorescent substances called fluors . 
Emitted B-particles contact solvent molecules and transfer some 
of their energy to these molecules yielding excited sol vent 
molecules. Excited solvent molecules transfer their excitation 
to other solvent molecules and eventually to a primary fluor 
molecule which then emits a photon . The photons emitted are 
then detected by a phototube-photomultiplier (Clark and Switzer, 
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1977) . 
3.1.1 MATERIALS AND METHODS 
5-Hydroxy [side chain-2-U C] tryptamine creatinine sulphate in 
aqueous solution containing 2% ethanol was purchased from 
Amersham International, U.K. The specific activity and 
radioactive concentration were respectively 53mCi/mmol and 50 
J..ICi/ml. 
The BGJb culture medium (Fitton-Jackson modification) with L-
glutamine was purchased from Gibco, U.K. The culture medium was 
fortified with the antibiotics streptomycin (0,1 mg/m1), 
penicillin (100 units/ml) and amphotericin B (2,5 J..I1ml). 
The 0,25mm Kieselgel 60 G254 thin layer chromatography plates 
were purchased from Merck, Germany. 
The Van Urks Reagent used for visualizing the spots on the TLC 
plates was made by adding a solution made up of 2g of 4-
dimethyl amine-benzaldehyde in 100ml of 25% HCI to lOamI of 90% 
ethanol. 
A solution of the indoleamine standards was prepared by 
dissolving 1mg of each of the 8 indoleamine standards (5-HT, 5-
MT, NAS, MEL, 5-HIAA, 5-MIAA, 5-HTOH, 5-MTOH) in 2,5ml of a 
solution of 95% ethanol. To this, 2,5ml of a solution of 1% 
ascorbic acid in O,lM-HCI was added. The standards were stored 
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in the dark at -20°C. 
Thin layer chromatography: Solvent A was prepared by mixing 
chloroform, methanol and glacial acetic acid in the ratio 
93:7:1. 
Solvent B was ethyl acetate. 
The scintillation cocktail used was Ready-Solv'" MP (multi-
purpose), purchased from Beckman, Scotland . 
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3.1.2 COMPOSITION OF BGJb MEDIUM USED FOR ORGAN CULTURE 
STUDIES (FITTON-JACKSON MODIFICATION) 
The mean tonicity of this medium is 390 milliosmoles. 
COMPONENTS 
Inorganic salts 
Dihydrogen sodium ortho phosphate 
Magnesium sulphate . 7H,O 
Potassium chloride 
Potassium dihydrogen phosphate 
Sodium bicarbonate 
Sodium chloride 
other components 
Calcium lactate 
Glucose 
Phenol red 
Sodium acetate 
Amino acids 
L-Alanine 
L-Arginine 
L-Aspartic acid 
L-cysteine HCI 
Glycine 
L-Histidine 
L-Isoleucine 
L-Leucine 
L-Lysine 
mgtl 
90,00 
200,00 
400,00 
160,00 
3 500,00 
5 300,00 
555,00 
10 000,00 
20,00 
50,00 
250,00 
175,00 
150,00 
90,00 
800,00 
150,00 
30,00 
50,00 
240,00 
COMPONENTS 
Amino acids (continued) 
L-Methionine 
L-Phenylalanine 
L-Proline 
L-Serine 
L-Threonine 
L-Tryptophan 
DL-Valine 
vitamins 
Alpha tocopherol phosphate 
Ascorbic acid 
Biotin 
Calcium panthothenate 
Choline chloride 
Folic Acid 
Inositol 
Nicotinamide 
Para aminobenzoic acid 
Pyridoxal phosphate 
Riboflavin 
Thiamine hydrochloride 
vitamin B12 
Supplements 
L-Glutamine 
Benzyl penicillin 
Streptomycin sulphate 
Amphotericin B 
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mgll 
50,00 
50,00 
400,00 
200,00 
75,00 
40,00 
65,00 
1,00 
50,00 
0,20 
0,20 
50,00 
0,20 
0,20 
20,00 
2,00 
0,20 
0,20 
4,00 
0,04 
200,00 
100,00 units/ml 
0,1 mg/ml 
2,5 J.lg/ml 
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3.1. 3 SEROTONIN METABOLISM IN RAT PINEAL ORGAN CULTURE 
3.1.3.1 Introduction 
The pineal gland in organ culture is able to metabolize 
serotonin to its various metabolites. If radiolabelled 
serotonin is used during incubation, the radioactivity would be 
manifested in all the indoleamine metabolites. Measurement of 
the radioactivity on the scintillation counter would give a good 
indication of the relative levels of the various indoleamine 
metabolites of radiolabelled serotonin. This technique could 
therefore be used to determine the effect of various chemical 
agents on the pineal enzymes responsible for metabolizing 
serotonin and consequently the effect of these agents on the 
relative levels of serotonin metabolites. Studies were carried 
out to determine how serotonin metabolism in rat pineal organ 
cultures would respond to various manipulations by the gonadal 
sex steroids. 
3.i.3.1.1 Materials and Methods 
Five rats were sacrificed and their pineal glands were rapidly 
removed. Each pineal gland was placed in an incubation tube 
containing 90~1 of BGJb culture medium . 10~1 of (side chain-2-
"C)-serotonin creatinine sulphate was then added . The 
inCUbation tubes were gassed with carbogen (95% 0 2 ; 5% CO2 ). 
The inCUbation tubes were firmly covered and the pineals were 
incubated in the dark at 37°C for 24 hours . The reaction was 
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stopped at the end of 24 hours by removing the pineal gland from 
the culture medium. A 10~1 aliquot of the culture medium was 
twice spotted on the TLC plate measuring 10cm x 10cm. A gentle 
stream of nitrogen gas was used to dry the spot after each 
spotting of the culture medium. Finally, standards of all the 
serotonin metabolites under study were spotted on top of the 
culture medium spot, once again allowing a gentle flow of 
nitrogen gas to dry the spots. Drying the spots with nitrogen 
gas prevents atmospheric oxidation of the metabolites . 
After spotting, the TLC plates were placed in TLC tanks 
containing TLC solvent A. The solvent was allowed to move up 
the TLC plate, reaching a height of 7cm. The plate was then 
removed from the tank, dried by a gentle flow of nitrogen and 
then placed back in the same sol vent to run in the same 
direction. After the sol vent front reached a height of 7cm, the 
TLC plate was taken out again, dried under nitrogen, turned 90° 
and then placed in the second TLC tank containing TLC solvent B. 
All the runs were performed in total darkness by placing a light 
proof box over the TLC tanks (Klein and Notides, 1969). 
The ethyl acetate was evaporated off with a gentle stream of 
nitrogen gas and the spots on the plates were visualized by 
spraying with Van Urks reagent . The plates were then placed in 
an oven at 60°C for 20 min to allow for the development of the 
spots . After development, the spots were scraped off the TLC 
plate into scintillation vials . lml of 95% ethanol was added to 
the scrapings in the vials followed by 3ml of scintillation 
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cocktail. The radioactivity of the various metabolites was 
measured on a Beckman LS 3801 scintillation counter. In 
preliminary studies, individual standards were chromatographed 
in this manner to identify the location of all the various 
metabolites . 
3.1.3.1.2 Results 
Blanks were run in exactly the same way except that no tissue 
was included. The blank values were subtracted from the results 
before expressing results. The results were expressed as the 
d.p.m. per 10~1 of culture medium. 
3.1.3.1 . 3 Discussion 
(See Fig . 23) 
The standards of the indoleamines were spotted on the same spot 
as the culture medium. The essence of this was to enable 
visualization of the spots on the plate since the concentrations 
of "the various indoleamines in the culture medium were so small 
they may not be detected with the Van Urks reagent . There was 
an appreciable level of separation of all the metabolites. 5-HT 
and 5-MT however remained at the origin, where the medium was 
spotted . The levels of radioactivity counted in all the 
metabol i tes were detectable. 
Solvent A 
Chloroform 93 
Methanol 7 
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Solvent B. 
Ethyl acetate 
Glacial acetic acid 1 
MTOH MlAA HTOH 
o o o 
< Solvent A (2x) 
HIM 
o 
O 5HT SHT 
Fig 23. Tracing of chromatographic separation of pineal 
indole compounds. 
5HT = Serotonin 5MT = 5-Hethoxytryptamine 
NAS = N-acetylserotonin 
MEL = Melatonin 
MTOH = Methoxytryptophol 
MIM = Methoxyindoleacetic acid 
HTOH = Hydroxytryptophol 
HIM = Hydroxyindoleacetic acid . 
(Oaya, 1982) 
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3.1.3.2 Effects of Testosterone on the Metabolism of "C-
Serotonin by Organ CUltures of Pineals from Castrated 
Male Rats 
3.1.3.2.1 Introduction 
since the sex organs, the gonads, are responsible for producing 
the sex hormones in the animals, it became logical to look at 
the effect of orchidectomy and ovariectomy and the direct 
influence of testosterone, progesterone and estradiol in the 
culture medium on "C-serotonin metabolism by the rat pineals in 
organ culture. 
3.1.3.2.2 Materials and Methods 
A stock solution of testosterone was made up in 95% ethanol . 
This was appropriately diluted to produce a final conc. of 10nM 
in the organ culture medium. A total of 15 male rats weighing 
between 200g and 300g, 10 of which had been castrated two weeks 
earlier, were used for this study. The castrated rats were 
divided into 2 groups of 5 rats each . After sacrifice, the 
pineals of the first group of castrated rats were cultured in 
the presence of radiolabelled serotonin and 10nM testosterone. 
The pineals of the second group of castrated rats and the intact 
rats were cultured in the presence of radiolabelled serotonin 
and the vehicle. After 24 hours, the incubation was terminated 
and 10~1 aliquots of the media were chromotographed in duplicate 
and the radioactivity of the various metabolites was measured as 
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described earlier (3.1.3 . 1.1) . 
3.1.3.2.3 Results 
As shown in Table 8 and Fig.24. 
The levels of MEL, HIAA, MIAA and HTOH were significantly higher 
in the pineal cultures from castrated rats incubated in the 
presence of testosterone relative to pineal cultures from 
castrated and intact rats which were incubated with the vehicle 
i . e . diluted 95% ethanol. MTOH levels were expectedly lower in 
the latter group compared to the former group. 
3.1.3.2.4 Discussion 
The levels of various indoleamine metabolites of serotonin in 
organ cultures would depend to a large extent on the activities 
of the various pineal enzymes responsible for synthesizing these 
indoleamines. The results indicate that, there was a 
significant increase in the levels of MEL, HIAA, MIAA and HTOH 
in . the pineal cultures from castrated rats incubated with 
testosterone compared to the pineal cultures from castrated and 
intact rats which were incubated with the vehicle. The higher 
levels of 5-MT and MIAA were consistent with the observation 
(Nagle et al., 1974) that, castration exerts inhibitory effects 
on pineal HIOMT activities of male rats which are opposite to 
the effects observed after testosterone administration in low 
doses. The higher levels of 5-MT and MIAA in the testosterone-
treated pineal cultures might therefore be a direct consequence 
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of the increased activity of HIOMT. The elevated levels of HIAA 
and HTOH in the testosterone-treated pineal cultures relative to 
the other groups might suggest that testosterone might exert a 
possible modulatory effect on the activities of the two pineal 
enzymes; aldehyde dehydrogenase and alcohol dehydrogenase. 
The observation of higher levels of MEL in the testosterone-
treated pineal cultures compared to the other groups was 
consistent with the finding by Karasek et ai., (1978) that 
castration can bring about a decrease in pineal concentration of 
cAMP. SNAT is stimulated by pineal cAMP, potentiating its 
activity of synthesizing NAS and MEL from serotonin. Therefore, 
any effect that brings about reduction in the concentration of 
cAMP would most certainly exert a consequent reduction in the 
activity of SNAT. The low levels of NAS observed in the 
testosterone-treated pineal cultures were contrary to the 
established observations in the literature. The results of the 
experiment show that testosterone can influence most of the 
pineal enzymes responsible for synthesizing the various 
indoleamines in pineal organ cultures and as a result influence 
the various levels of the indoles during organ culture. 
The precise mechanism of testosterone on pineal metabolic 
activity is yet to be elucidated since present literature 
reports 
reported 
are conflicting. Cardinali et ai., 
that the rat pineal can aromatize 
(1974b) have 
radiolabelled 
testosterone into estrone and estradiol in vivo and in vitro. 
Pres lock (1975), further observed that, al though these 
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conversion rates of testosterone into androgens and estrogens 
are relatively low, it is possible that testosterone is 
converted into these metabolites within the pineal prior to 
exerting biological acitivity. This is not however consistent 
with Daya's (1985) observation that the stimulatory activity of 
testosterone is not dependent on prior conversion of 
testosterone to estradiol. Further work is required to clarify 
this position. 
SEROTONIN 
METABOLITE 
NAS 
MEL 
HIAA 
MIAA 
HTOH 
MTOH 
(A) 
Intact rat 
pineals 
553,7 ± 40 
357,1 ± 10 
13 237,3 ± 200 
563,3 ± 50 
3 609,1 ± 100 
1 273,5 ± 150 
DPM READINGS/I0~1 culture medium ± S.E.M. 
(B) 
Castrated 
rat pineals 
703,3 ± 38 
372,2 ± 15 
13 561,1 ± 300 
497,8 ± 25 
4 303,3 ± 100 
857,6 ± 50 
Significance 
student t test 
P < 0,05 
N. S. 
P < 0,01 
P < 0,05 
P < 0,05 
P < 0,05 
(C) 
Castrated 
rat pineals 
incubated with 
Testosterone 
657,9 ± 50 
1 113,5 ± 67 
16 656,1 ± 250 
703,9 ± 37 
6 307,4 ± 250 
903,7 ± 57 
Significance 
compared 
to B 
students t test 
N.S. 
P < 0,01 
P < 0,05 
P < 0,05 
P < 0,05 
N.S. 
5HT._5MT 80 231.6 ± 1 500 50 300.1 ± 1 405 P < 0.01 90 531.0 ± 1 750 P < 0.005 
TABLE 8. effect of orchidectomy and the direct influence of testosterone on radiolabelled serotonin 
metabolism in rat pineal organ cultures. Pineals were cultured for 24 hours in the 
presence of radiolabelled serotonin and ethanol (A and B) and in the presence of 
radiolabelled serotonin and 10nM testosterone (C). (n = 4) 
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serotonin metabolite 
Fig. 24. effect of orchidectomy and direct influence of testosterone on 
radial.belled serotonin metabo l i sm in rat pineal organ cultures 
A. pineals from intact rats were incubated with the vehicle 
8. pineals from castr ated rats were incubated with the vehicle 
C. pineals from castrated rats were incubated with testosterone 
C compared to 8 * N. S. !p < 0.05 
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3.1.3.3 Effect of Progesterone on the Metabolism of uC-
serotonin by Organ cultures of Pineals from 
ovariectomized Female Rats 
3.1.3.3.1 Materials and Methods 
A solution of progesterone in 95% ethanol was prepared and 
diluted to give a final concentration of 10nM in the culture 
medium . Fifteen female rats, weighing 200-250g, 10 of which had 
been ovariectomized two weeks earlier were used for this study. 
The ovariectomized rats were divided into two groups of 5 rats 
each. After sacrifice, the pineals of the first group of 
ovariectomized rats were incubated with uC-serotonin in the 
presence of 10nM progesterone. The pineals of the second group 
of ovariectomized rats and intact rats were incubated with 
radiolabelled serotonin and the vehicle. After 24 hours of 
incubation, 10~1 aliquots of the media were chromotographed and 
the radioactivity of the various metabolites were determined as 
described earlier (3.1.3.1.1). 
3.1.3.3.2 Results 
As shown in Table 9 and Fig.25 . 
3.1.3.3.3 Discussion 
Presently, there are no literature reports on the effect of 
ovariectomy and the direct influence of progesterone on the 
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metabolism of radiolabelled serotonin 
cultures. Daya (1982) has observed 
by female rat pineal 
that low doses of 
progesterone administered chronically stimulates HIOMT activity 
whereas higher doses administered chronically inhibit HIOMT 
activity. However, the progesterone used for this study was 
administered in pharmacological doses. 
From the results however, there was a significant increase in 
the levels of MEL, HIM and HTOH in the ovariectomized rat 
pineal cultures incubated with progesterone compared to the 
ovariectomized rat pineal cultures which were incubated with the 
vehicle . It appears that, at physiological concentrations, the 
sex hormone has a stimulatory role in the melatonin synthesis 
pathway. 
SEROTONIN DPM READINGS/l0~1 culture medium ± S.E.M. 
METABOLITE ( A) (B) (C) 
Intact rat Ovariectomized Significance ovariectomized significance 
pineals rat pineals student t test rat pineals compared 
incubat~d with to B 
Proqesterone students t test 
NAS 203,6 ± 5 250,3 ± 9 P < 0,05 97,3 ± 4 P < 0,05 
MEL 135,7 ± 6 99,5 ± 4 P < 0,05 150,7 ± 6 P < 0,05 
HIAA 20 564,9 ± 145 10 516,8 ± 103 P < 0,01 25 013,3 ± 170 P < 0,005 
MIAA 300,1 ± 11 385,8 ± 10 N.S. 360,7 ± 15 N. S. 
HTOH 3 951,7 ± 95 3 261,3 ± 56 P < 0,05 4 307,7 ± 81 P < 0,01 
MTOH 457,3 ± 15 497,9 ± 11 N.S. 487,6 ± 20 N.S. 
5HT o_SMT 37 307.6 ± 900 50 016.0 ± 800 P < 0.005 40 103.5 ± 1 003 P < 0.05 
TABLE 9. effect of ovariectomy and the direct influence of progesterone on radio labelled serotonin 
metabolism in rat pineal organ cultures. pineals were cultured in the presence of 
radiolabelled serotonin and ethanol (A and B) and in the presence of radiolabelled 
serotonin and 10nM progesterone. 
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Fig. 25. effect of ovariectomy and the direct influence of progesterone on 
radiolabe l led serotonin metabolism in rat pineal organ cultures 
A. pineals from intact rats were incubated with the vehicle 
B. pineals from ovariec~omized rats were incubated with the 
vehicle 
C. pineals from ovariectomized rats were incubated with 
progesterone 
C compared to B • N.S. :p < 0. 05 • :p<O.OI • : p < 0.005 
• 
3.1.3.4 
134 
Effect of Estradiol on the Metabolism of "C-Serotonin 
by Organ Cultures of Pineals from OVariectomized 
Female Rats 
3 . 1 . 3.4.1 Materials and Methods 
A stock solution of B-estradiol-3-benzoate in 95% ethanol was 
prepared and this was diluted to give a final concentration of 
10nM in the culture medium. Fifteen female rats weighing 
between 200g and 250g, 10 of which had been ovariectomized two 
weeks earlier were used for this study. The ovariectomized rats 
were divided into two groups of 5 rats each . The pineals of the 
first group of ovariectomized rats were incubated with 
radiolabelled serotonin and 10nK B-estradiol-3-benzoate after 
sacrifice. The pineals of the second group of ovariectomized 
rats and intact rats were incubated with radiolabelled serotonin 
and the vehicle. After 24 hours of incubation, 10~1 aliquots of 
the media were chromatographed and the radioactivity of the 
various serotonin metabolites were determined as described 
earlier (3.1.3.1.1). 
3.1.3 . 4.2 Results 
As shown in Table 10 and Fig.26. 
Estradiol appeared to have significantly enhanced HIOMT 
activity. 
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3.1.3.4.3 Discussion 
In recent years, evidence has accumulated which indicates the 
pineal gland may be a target organ of steroid hormones. The 
pineal gland has been shown, both in vivo and in vitro to take 
up and retain estradiol (Marks et a1 . , 1972; Nagle et a1" 
1972; Nagle et a1., 1973; Carinalli et a1 . , 1975) . It has 
also been reported that pineal cells contain cytosol as well as 
nuclear components capable of binding estradiol (Mark et a1., 
1972; Cardinali et a1., 1975), suggesting the possibility that 
the mode of action of estradiol in the pineal conforms to the 
general scheme of steroid hormone action accepted in other 
target organs, particularly in the uterus (Mizobe and Kurokawa, 
1976; Jensen et a1., 1971; O'Malley et a1., 1974). 
There was a significant increase in the MEL levels with a 
concomitant decrease in NAS levels in the ovariectomized rat 
pineal cultures incubated with estradiol relative to 
ovariectomized rat pineals incubated with the vehicle. 
This observation suggested estradiol might have potentiated the 
acti vi ty of HIOMT but not SNAT. The stimulatory effect of 
estradiol on HIOMT was also manifested in the significant 
increase in the levels of MIAA in the cultures incubated with 
estradiol compared to cultures incubated with the vehicle . 
However, depressed levels of MTOH was observed in the pineal 
cultures incubated with estradiol . This observation might lend 
support to the hypothesis of the presence of different HIOMT 
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enzymes in the pineal. The stimulatory effect of estradiol on 
pineal HIOMT is in accord with the observations by Mizobe and 
Kurokawa (1976) that estradiol significantly increased HIOMT 
activity in a dose-dependent manner within the concentration 
range from 0,1 to 15nM. This is the range of physiological 
concentration of estradiol in the ovarian venous blood of rats 
(Hori et al., 1979). 
Ovariectomy depressed HIOMT activity in female rats as has been 
observed by Cardinali (1974). Cardinali et al., (1974b) also 
observed a decrease in pineal protein synthesis in 
ovariectomized female rats. The consequence of this might be a 
reduced synthesis in HIOMT protein and hence a reduced HIOMT 
activity. 
The higher levels of NAS in the pineal cultures of 
ovariectomized rats incubated with the vehicle relative to the 
pineal cultures of ovariectomized rats incubated with estradiol 
were in agreement with the observation that estradiol has no 
stimulatory effect on pineal SNAT (Illnerova, 1975); (Preslock, 
1974 and 1975). Estradiol might have however played a 
modulatory role in the activities of aldehyde dehydrogenase and 
alcohol dehydrogenase in view of the significant increases in 
the levels of HIAA and HTOH in estradiol-treated cultures but 
not in the vehicle-treated cultures. 
It appears quite surprising that estradiol has no modulatory 
effect on SNAT activity in view of Preslock's (1977) observation 
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that testosterone is converted into estradiol before exerting 
biological activity. A possible explanation here is that there 
may be slight structural differences between endogenous 
estradiol metabolized from testosterone and exogenous estradiol. 
SNAT may be sensitive to these differences. 
SEROTONIN DPM READINGS/I0~l culture medium ± S.E.M. 
METABOLITE (A) (B) (C) 
Intact rat Ovariectomized Significance ovariectomized Significance 
pineals rat pineals student t test rat pineals compared 
incubated with to B 
estradiol students t test 
NAS 75,4 ± 3 103,7 ± 5 P < 0,05 83,1 ± 4 P < 0,05 
MEL 250,3 ± 10 123,3 ± 6 P < 0,005 257,8 ± 9 P < 0,005 
HIAA 15 601,7 ± 201 14 351,7 ± 105 P < 0,05 17 532,9 ± 150 P < 0,005 
MlAA 431,7 ± 30 280,3 ± 15 P < 0,001 582,3 ± 21 P < 0,001 
HTOH 3 998,1 ± 251 2 561,1 ± 207 P < 0,05 3 864,7 ± 273 P < 0,05 
MTOH 653,7 ± 25 957,3 ± 25 P < 0,05 589,9 ± 10 P < 0,05 
5HT. 5MT 70 512.5 ± 859 39 561. 3 ± 657 P < 0.005 68 512.3 ± 963 P < 0.05 
TABLE 10. effect of ovariectomy and the direct influence of estradiol on radiolabelled serotonin 
metabolism in rat pineal organ cultures. Pineals were cultured in the presence of 
radiolabelled serotonin and ethanol (A and B) and in the presence of radiolabelled 
serotonin and 10nM estradiol (C). 
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Fig. 26 . effect of ovariectomy and the direct influence of estradiol on 
radio1abe11ed serotonin metabolism in rat pineal organ cultures 
A. pineals from intact rats were incubated with the vehicle 
B. pineals from ovariectomized rats were incubated with the 
veh ic 1e 
C. pineals from ovariectomized rats were incubated with estradiol 
.. 
C compared to B : p < O. OS !p < 0.005 
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Effect of Testosterone on Nocturnal Levels of uC_ 
Serotonin Metabolites in Organ CUltures of Pineals 
from castrated Male Rats 
3 . 1 . 3 . 5.1 Introduction 
The pineal gland is the site at which light:dark information is 
translated, or transduced, into a chemical messenger. The 
pineal gland, in essence, is the intermediary between the 
external photoperiod (perceived through the eye) and the 
internal milieu (Reiter, 1991). The eyes communicate with the 
pineal by a neuronal route which includes the retinohypothalamic 
tract, the suprachiasmatic nuclei and the pre- and 
postganglionic fibres of the peripheral sympathetic nervous 
system (Reiter, 1981) . 
with the onset of darkness, the sympathetic nerves innervating 
the pineal gland are stimUlated . This results in the activation 
of adenyl ate cyclase which converts ATP to cAMP . cAMP in turn 
stimulates SNAT and HIOMT, the two pineal enzymes responsible 
for converting serotonin into melatonin. Consequently, the rat 
pineal concentration of serotonin and melatonin follow an 
inverse relationship (Romero, 1976; Relkin, 1976 ; Quay, 1974; 
Wolstenholme, 1971; Wurtman et al., 1968) . 
3.1.3.5.2 Materials and Methods 
Male rats with a mass of 200g-300g, 10 of which had been 
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castrated two weeks earlier were used for this study. 
six hours prior to sacrifice, the rats were housed in cupboards 
in a dark room secured from all incoming light. The room was 
kept lit with a dim red light. Red light does not influence the 
pineal enzymatic activities. The rats were sacrificed at 23hOO 
and the pineals rapidly removed . Five pineals from the 
castrated group were incubated with 10nM testosterone. The 
pineals from the five remaining castrated rats and the 5 pineals 
from the intact rats were incubated with the vehicle. 
The incubation was stopped after 24 hours and 10~1 aliquots of 
the various media were chromatographed. The radioactivity of 
the various serotonin metabolites were determined as described 
earlier. 
3 . 1.3.5.3 Results 
As shown in Table 11 and Fig.27. 
The diurnal variation in pineal MEL synthesis was evident when 
these results were compared to those of the daytime study 
( 3 .1. 3 . 2 . 3). Castration seemingly reduced the nocturnal rise in 
SNAT acti vi ty. Testosterone appeared to have restored the 
reduced nocturnal activity of SNAT. 
3.1.3.5.4 Discussion 
The relative levels of radioactivity of the various indoleamines 
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were indicative of their levels in the medium after HC-Serotonin 
metabolism. Comparing the results from this study to the 
results obtained from the daytime study (see Table 8), it is 
evident that there was a diurnal variation in MEL levels in 
relation to the photoperiod which came about as a consequence of 
the already established diurnal variation in SNAT activity (from 
literature reports). The nocturnal levels of MEL were 
signficantly higher than the levels in the daytime study. This 
is in agreement with previous reports (Sheving et al., 1961; 
Okada, 1971; Fernstrom and Wurtman, 1971). Axelrod (1974) has 
observed that melatonin synthetic and secretory activity of the 
pineal gland is determined primarily by the release of 
norepinephrine from postganglionic sympathetic nerve endings 
that terminate in the gland (Kappers, 1960). The release of 
norepinephrine is strictly associated with darkness when the 
suprachiasmatic nuclei are relieved of the inhibitory signal 
from the eyes due to interaction of photons with the retinas 
(Reiter, 1991). Klein and Weller, (1970), Deguchi and Axelrod, 
(1972) have also reported the diurnal variations in SNAT 
activity. 
The results also indicate that castration of the rats appeared 
to have resulted in a decrease of the nighttime elevation of 
SNAT activity. Castration has been shown (Karasek et al., 1978) 
to reduce the pineal concentration of cAMP. This consequently 
reduces SNAT activity since cAMP plays an essential stimulatory 
role on the activity of SNAT. Pavlinov and Isachenkov (1979) as 
well as Rudeen and Reiter (1980) have published similar 
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observations about reduction in the nocturnal rise of SNAT 
activity in castrated male rats. Their results also show that 
testosterone replacement restored the reduced nocturnal activity 
of SNAT. This shows that testosterone could regulate the 
activity of SNAT. 
SEROTONIN 
METABOLITE 
NAS 
MEL 
HIAA 
MIAA 
HTOH 
MTOH 
(A) 
Intact rat 
pineals 
1 505,3 ± 97 
1 793,5 ± 106 
18 644,7 ± 500 
165,4 ± 13 
4 108,4 ± 375 
91,3 ± 6 
DPM READINGS/10~l culture medium ± S.E.M. 
(C) (B) 
Castrated 
rat pineals 
1 023,7 ± 67 
1 209,3 ± 53 
7 361,3 ± 381 
91,8 ± 6 
1 495,2 ± 105 
104,1 ± 7 
Significance 
student 
t test 
P < 0,05 
P < 0,01 
P < 0,05 
P < 0,05 
P < 0,005 
N.S. 
Castrated Significance 
rat pineals compared 
incubated with to B 
testosterone students t test 
2 073,7 ± 123 P < 0,005 
2 204,3 ± 140 P < 0,005 
12 644,1 ± 603 P < 0,05 
252,9 ± 7 P < 0,05 
4 773,7 ± 250 P < 0,01 
110,3 ± 6 N.S. 
5HT, 5MT 30 149,3 + 1 200 54 488,3 + 1 501 P < 0,05 70 626,7 ± 1 803 P < 0,005 
TABLE 11. effect of testosterone on nocturnal levels of "C-serotonin metabolites in organ cultures 
of pineals from castrated male rats. Pineals were cultured in the presence of 
radiolabelled serotonin and ethanol (A and B) and in the presence of radiolabelled 
serotonin and 10nM testosterone (C). 
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fig. 27 effect of testosterone on nocturnal levels of 14C- serotonin metab-
olites in organ cultures of pineals from castrated rats 
A. pineals from intact rats were incubated with the vehicle 
B. pineals from castrated rats were incubated with the vehicle 
C. pinea ls from castrated rats were incubated with testosterone 
C compared to 8 • N. S. :p < 0. 05 • :p < 0. 01 • !p < 0.005 
• 
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Effect of Estradiol on Nocturnal Levels of "C-
Serotonin Metabolites in Organ Cultures of Pineals 
from ovariectomized Female Rats 
3.1.3.6.1 Materials and Methods 
Fifteen female rats with a mass of 200-250g, 10 of which had 
been ovariectomized two weeks earlier were used for this study. 
The rats were kept in the dark before sacrifice as already 
described in 3.1.3.5.2. At 23hOO, the rats were killed and the 
pineals were rapidly removed. Five pineals from the 
ovariectomized group were cultured with 10nM estradiol. The 
pineals from the five remaining ovariectomized rats as well as 
those from the 5 intact rats were incubated with the vehicle. 
The incubation was stopped after 24 hours and 10~1 aliquots of 
the various media were chromatographed. The radioactivity of 
the various serotonin metabolites was determined as described 
earlier (3.1.3.1.1). 
3.1.3.6.2 Results 
As shown in Table 12 and Fig.28. 
The nocturnal levels of MEL were higher than in the daytime 
study. There was no significant difference between MEL levels 
in cultures of ovariectomized rats incubated with estradiol 
relative to those incubated with the vehicle. 
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3.1.3.6.3 Discussion 
The nocturnal levels of MEL were significantly higher than the 
levels during daytime . This is consistent with literature 
reports (Sheving et al., 1961; Okada,1971). At present, 
however, there are no reports in the literature on the effect of 
estradiol and ovariectomy on the nighttime metabolism of 
radiolabelled serotonin. 
comparing MEL levels in the pineal cultures of ovariectomized 
rats incubated with estradiol to the MEL levels of the cultures 
of ovariectomized rats incubated with the vehicle, there were no 
statistically significant differences. This probably shows that 
estradiol did not exert any modulatory effect on SNAT activity. 
However, the significant increase in MEL levels in the pineal 
cultures of intact rats compared to the other two groups shows 
clearly that ovariectomy causes a depression in MEL synthesis. 
SEROTONIN 
METABOLITE 
NAS 
MEL 
HIAA 
MIAA 
HTOH 
MTOH 
(Al 
Intact rat 
pineals 
80,3 ± 5 
1 593,2 ± 76 
13 061,1 ± 185 
681,7 ± 53 
2 547,1 ± 153 
447,6 ± 31 
DPM READINGS/10~l culture medium 
(B) 
± S.E.M. 
ee) 
Ovariectomized 
rat pineals 
incubated with 
estradiol 
Ovariectomized Significance 
rat pineals 
97,6 ± 6 
186,7 ± 11 
12 983,7 ± 102 
482,9 ± 41 
2 337,6 ± 125 
586,3 ± 38 
student 
t test 
N. S. 
P < 0,005 
N.S. 
P < 0,005 
N. S. 
P < 0,05 
79,3 ± 6 
193,7 ± 8 
12 501,5 ± 120 
547,3 ± 25 
2 010,1 ± 102 
431,8 ± 26 
5HT. 5MT 60 101.6 ± 603 56.703.7 ± 567 P < 0.05 59 567 + 593 
Significance 
compared 
to B 
students t test 
N.S. 
N. S. 
N.S. 
N.S. 
N. S. 
P < 0,05 
N. S. 
TABLE 12. effect of estradiol on nocturnal levels of "e-serotonin metabolism in rat pineal organ 
cultures of pineals from ovariectomized female rats. Pineals were cultured in the 
presence of radiolabelled serotonin and ethanol (A and B) and in the presence of 
radiolabelled serotonin and lOnM estradiol ee). 
f-> 
.... 
OJ 
" 
'" 
" 
" " 
" o 
~ 
3 
.... 
i 
~ 
" .. .... 
" u 
.... 
:1 
o 
149 
14 
8 
~ 21-................ -.. ··.-.·.·--.. ··---... ·.· 
f 
c 
NAS MEL HAA MIAA HTOH MTOH 
Serotonin metabolite 
Fig . 28. effect of estradiol on nocturnal levels of 14C-serotonin metabo-
lites in organ cultures of pineals from ovariectomized female rats 
A. pineals from intact rats were incubated with the vehicle 
B. pineals from ovariectomiaed rats were incubated with the 
vehicle 
C. pineals from ovariectomized rats were incubated with estradiol 
C compared to B • H. S. : p < 0 . 05 
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3 . 1.3.7 
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Cumulative Effect of Testosterone and Isoprenaline on 
··C-Serotonin Metabolism by Rat Pineals in Organ 
Culture 
3.1.3.7.1 Introduction 
wurtman et aI., (1971) have established through organ culture 
studies that the noradrenaline-induced stimulation of pineal 
synthesis of HC-melatonin and HC-serotonin is inhibited by 
propranolol, a B-adrenergic blocker and not by phenoxybenzamine, 
an a-adrenergic blocker. This observation implied that the 
stimulation mechanism involved B-receptors. Prior to this 
Kappers (1960) had established that the pineal was innervated by 
the sympathetic nerves. The neurotransmitter was identified as 
noradrenaline (Wolfe et aI., 1962; Pellegrino de Iraldi and 
Zieher, 1966). Backstrom (1977), using selective B. and B2 
agonists and antagonists in rat pineal organ cultures, showed 
that the adrenoreceptors in the rat pineal respond similarly to 
the B. ad reno receptor subgroup. The physiological dispositions 
of -isoprenaline, a B-agonist are identical to noradrenaline. 
Isoprenaline could therefore stimUlate the B-receptors and this 
stimulation could lead to the activation of adenyl ate cyclase 
(Weiss and Costa, 1967; Weiss, 1971; Weiss and Strada, 19.72). 
Cyclic AMP in turn activates SNAT and HIOMT, the two pineal 
enzymes responsible for converting serotonin to melatonin. 
Isoprenaline would therefore be expected to enhance melatonin 
synthesis in the pineal gland . Since testosterone exerts a 
stimUlatory effect on SNAT activity, this study was carried out 
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to observe the cumulative effect of isoprenaline and 
testosterone on melatonin synthesis by rat pineals i n organ 
cultures. 
3.1.3.7.2 Materials and Methods 
Isoprenaline was purchased from Sigma Chemical Company, Mo, USA . 
Fifteen male rats weighing between 200 and 300g were used for 
this investigation. The rats were sacrificed and the pineals 
removed. The pineals of the first group of 5 rats were 
incubated in BGJb medium with testosterone and isoprenaline 
solutions each with a final concentration of 10nM. The second 
group of five pineals were incubated with testosterone and the 
third group of pineals were incubated in the presence of the 
vehicle . 
After 24 hours, 10~1 aliquots of the media were chromotographed 
on TLC plates as described earlier. The radioactivity was then 
read on the scintillation counter . 
3.1.3.7.3 Results 
As shown in Table 13 and Fig . 29. 
The results show that testosterone potentiated isoprenaline 
effect on MEL synthesis . 
152 
3.1 . 3.7.4 Discussion 
Isoprenaline and testosterone together brought about a 
cumulative elevation in the levels of MEL in the culture medium 
which was significant compared to MEL levels in the pineal 
cultures incubated with either testosterone or the vehicle. 
This is consistent with the fact that isoprenaline, a B-agonist 
stimulates pineal SNAT via cAMP. Testosterone therefore 
amplified the isoprenaline response on the enhanced synthesis of 
melatonin . 
MEL 
LEVELS 
MEL 
LEVELS 
Pineals incubated 
with Testosterone 
and Isoprenaline 
(A) 
3 457,3 ± 106 
DPM readings/lO~l culture medium 
± S.E.M. 
Pineals incubated Significance 
with Testosterone 
student 
(B) t test 
883,1 ± 43 P < 0,01 
Pineals significance 
incubated compared to A 
with Ethanol students t test 
(C) 
396,7 ± 18 P < 0,005 
TABLE 13. Cumulative effect of testosterone and isoprenaline on melatonin levels in rat pineals in 
organ culture. Pineals were incubated with testosterone and isoprenaline (A), 
testosterone alone (B) and ethanol (C) all in the presence of radiolabelled serotonin. 
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~ 
A 
-B 
c 
Fig. 29. cumulative effect of testosterone and isoprenaline on melatonin 
synthesis in rat pineals in organ cultures 
A. pineals were incubated with testosterone and isoprenaline 
8. pineals were incubated with testosterone 
C. pineals were incubated with the vehicle 
A compared to B :p<O.Ol 
• 
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CHAPTER 4 
4.1 EFFECT OF GONADAL SEX STEROIDS ON L-[UC1-TRYPTOPHAN UPTAKE 
BY RAT CORTICAL S¥NAPTOSOMES 
4.1.1 INTRODUCTION 
The circadian variation in the concentration of serotonin in the 
rat brain has been well established in numerous literature 
reports (Sheving et al., 1968; Okada, 1971; Fernstrom and 
Wurtman, 1971). Plasma concentrations of L-tryptophan have also 
been shown to vary throughout the light-dark cycle (Fernstrom 
and Wurtman, 1971; Dam et al., 1984), although a correlation 
between plasma 'free' L-tryp and brain serotonin concentrations 
has not been readily discernable (Morgan et al., 1975). Beyond 
the blood brain barrier, however, L-tryp levels seem to 
correlate more closely with those of 5-HT and 5-HIAA (Morgan et 
al., 1975). It is believed that tryptophan hydroxylase is the 
rate-limiting step in the synthesis of 5-HT because it is 
unsaturated with respect to L-tryp (McGeer et al., 1968). 
Therefore the intra-synaptic concentrations of L-tryp would be 
expected to influence the rate of synthesis of serotonin. Thus 
the mechanism of uptake of L-tryp into nerve endings appear to 
be of prime importance in the study of the regulation of 
serotonin biosynthesis (Loizou and Redfern, 1988). 
Cortical synaptosomes are metabolically active, membrane-
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enclosed presynaptic nerve terminals resulting from 'pinching 
off' the nerve terminals at the point of connection with the 
axon, and are ideal for studying the neural synthesis of 
neurotransmitters such as serotonin. 
4.1.2 MATERIALS AND METHODS 
4.1.2.1 Animal.s 
Male and Female rats of the wistar strain, weighing between 200 
and 300g were used in the course of this study. The rats were 
given food and water ad libitum and they were subjected to a 12 
hours light : 12 hours dark cycle. 
4.1.2.2 Buffers and Sol.utions 
(i) Tris-HCl. buffer pH 7,2 
This was prepared by adding 250ml of O,2M-Tris (24,2g Tris/ 
1 OOOml) to 211ml of O,2N-HCI (7,3g HCl/I OOOml). The volume 
was then made up to 800m!. The pH of the resulting sol.ution was 
adjusted to 7,2 by the addition of O,lNHCI. Distilled water was 
added to make up for a final volume of 1 OOOml. This was kept 
refrigerated. 
(ii) O,32M-Sucrose sol.ution in Tris-HCl. buffer, pH 7,2 
This was prepared by dissolving 10,9g of sucrose in 100ml of 
Tris-HCI buffer. The solution was always kept ice-cold. 
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(iii) Krebs-Bicarbonate buffer pH 7 (for maintaining rat brain 
synaptosomes). 
This was prepared by dissolving the following chemicals in 
1 OOOml of distilled water. 
Chemical concentration Mass in g per 
(roM) 1 OOOml solution 
NaCI 11,84 0,692 
KCI 4,70 0,350 
MgSO,.7H,O 1,10 0,271 
KH,PO, 1,20 0,163 
NaHCO, 25 2,100 
glucose 11,10 2,000 
CaCI,.2H2 O 2,50 0,368 
This buffer was always prepared on the day of use. All the 
chemicals were purchased from the British Drug House, England. 
(iv) Protein Assay Solutions 
Solution A: 1% copper sulphate solution. prepared by 
dissolving 1,Og cuSO,.5H2 0 in 100ml distilled water. 
Solution B: 2% sodium tartrate solution. Prepared by 
dissolving 2,Og sodium tartrate in 100ml distilled water. 
Solution c: 2% sodium carbonate in O,IMHaOH. Prepared by 
dissolving 2.0g Na2 CO, and 0,4g NaOH in 100ml distilled water. 
solution D: This was prepared by mixing, in order, 1ml solution 
A, 1ml solution Band 98ml of solution c. This was always 
prepared before use (Clark and switzer, 1977). 
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Solution E: Folin-Ciocalteau reagent. 
(v) Protein standard Solution 
Prepared by dissolving 10mg of Bovine Serum Albumin in 10ml of 
distilled water. 
(vi) steroid hormones 
1mg/ml solutions of testosterone, progesterone and B-estradiol-
3-benzoate were prepared in olive oil. 
(vii) Radioactive L-[methylene-'4C]-Tryptophan 
was purchased from Amersham, England. The radio labelled 
tryptophan had a specific activity of 54~Ci/mmole and a 
radioactive concentration of 50~Ci/ml . 
(viii) Scintillation cocktail 
Ready - solv~ MP (Multi-purpose) was purchased from Beckman, 
switzerland. 
(ix) 'Cold' Tryptophan solutions 
This was prepared according to the procedure outlined in 
2.1.1.2. 
4.1.2.3 Preparation of synaptosomes 
After sacrifice and decapitation, the brain was removed and 
placed on a piece of filter paper in a Petri dish soaked with 
Krebs-bicarbonate buffer which was kept cold by placing on ice, 
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to prevent degradation. The two frontal cerebral hemispheres 
were dissected free, weighed and placed in enough ice cold 0,32M 
sucrose in Tris-HCI buffer, pH 7,2 to give a 10% w/v homogenate 
(Loizou and Redfern, 1988). 
The cortex was homogenized in a Wheaton glass mortar with a 
Teflon pestle until a homogenous suspension, free from all 
visible cellular matter was obtained. The glass mortar 
containing the brain tissue was kept on ice during the 
homogenization procedure. The homogenate was then centrifuged 
at 7 000 r.p.m. and 4°C for 10 minutes in a Hettich Universal 
K2S centrifuge with an angle head motor (catalog number 1375) to 
sediment out nuclei and cellular debris. 
The supernatant was recovered in pre-weighed centrifuge tubes 
and centrifuged at 25 000 r.p.m. and 4°C for 30 min in a Beckman 
L8-80M ultracentrifuge with a 70lTI rotor to sediment the 
synaptosomes. The supernatant from this centrifugation was 
discardered and the final pellet resuspended in Krebs-
bicarbonate buffer to give a 10% w/v suspension. 
4.1.2.4 Measurement of tryptophan uptake by synaptosomes 
The procedure began with the addition of 200~1 of synaptosomal 
suspension to 600~1 of Krebs-bicarbonate buffer in incubation 
tubes. After allowing 10 min for temperature equilibration, the 
assay was started by adding 200~1 of three typtophan solutions, 
containing 0, 2~Ci L- [methylene-HC ] - tryptophan and sufficient 
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'cold' L-tryptophan to give a final concentration of 0,01; O,OS 
and O,lmM. This was done in triplicate. The final reaction 
mixtures were shaken continuously during the S minutes 
incubation period. 
the synaptosomes 
The reaction was terminated by separating 
from the incubation medium by filtration 
through a Whatman GF/C 2,Scm glass microfibre filters which were 
presoaked with Krebs-bicarbonate and housed in 12-place 
Millipore sampling manifold. The retained synaptosomes were 
then washed three times with 2, Oml aliquots of Krebs-bicarbonate 
buffer. The filters with the washed synaptosomes were placed in 
scintillation vials to which was added 4, Sml scintillation 
cocktail. The filters were allowed to stand overnight in the 
dark to ensure synaptosomal rupture and release of the 
accumulated L-[ 14C]-tryptophan to minimize quenching by 
synaptosomal membranes (Loizou and Redfern, 1988). The 
radioactivity was then read on a Beckman LS3801 scintillation 
counter. 
4.1.2.5 Protein determination in synaptosome preparations 
The protein in each synaptosome preparation was determined by a 
slight modification of Folin-Lowry method. 1, 2ml of 
appropriately diluted protein sample was mixed with 6ml of 
solution D and left to stand for 10min at room temperature. 
0,3ml of solution E was then added, and the resulting solution 
was immediately mixed. The solution was allowed to stand for 30 
min at room temperature after which the absorbance was read on 
a Bausch and Lomb Spectronic 301 at SOOnm. Following the same 
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procedure and using Bovine Serum Albumin, a standard curve was 
drawn. 
4.1.3 
4 . 1.3.1 
EFFECT OF TESTOSTERONE ON L- [UC] -TRYPTOPHAN UPTAKE BY 
RAT CORTICAL SYNAPTOSOKES 
Materials and Methods 
10 male rats w3ighing between 200g and 300g were used for this 
study. The 5 rats in the test group were dosed with 0, lml 
testosterone, twice daily for 5 days. The 5 rats in the control 
group were similarly dosed with the vehicle. On the 6th day, 
the rats were sacrificed, decapitated and the brains were 
removed. Procedures for the preparation of the synaptosomes and 
L-[ " C]-tryptophan uptake as outlined in 4.1.2.3 were followed . 
4.1.3.2 Results 
As shown in Table 14 and Fig.30. 
The results show that testosterone significantly elevated the 
uptake levels of L-[UC]-tryptophan in the synaptosomal 
preparations. The results also do indicate that there was an 
increase in the uptake of radiolabelled L-tryptophan with an 
increase in the concentration of mixed 'hot' and 'cold' L-
tryptophan solution from 0,01mM to 0,05mM. However, there was 
a decrease in the uptake of radiolabelled L-tryptophan by the 
synaptosomes at the highest concentration of 0, lmM. This 
pattern of change in the uptake levels was observed in the test 
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group as well as in the control group. 
4.1.3.3 Discussion 
At present, there are no literature reports on the effect of 
testosterone on the uptake of L-tryptophan by the brain 
synaptosomes. However, it is evident from the results that 
testosterone signficantly enhanced· the uptake of L-tryptophan by 
the synaptosomal preparations. This may be a compensatory 
mechanism effected by testosterone to make up for the reduced 
levels of circulating tryptophan a consequence of the 
induction of liver tryptophan pyrrolase by testosterone. 
The non-sepcific binding was reduced by washing the tryp-
receptor complex after collection on a filter with aliquots of 
Krebs-bicarbonate solution. 
From a concentration of O,OlmM to O,05mM, there was a 
significant enhancement of "hot" L-tryptophan uptake by the 
synaptosomes in the Test as well as in the Control groups. A 
possible explanation here is, more of the "cold" L-tryp was 
involved in non-specific binding allowing the vesicles to 
specifically bind to the "hot" L-tryp. The decrease in "hot" L-
tryp uptake by the synaptosomes in the highest L-tryp 
concentration of 0, 10mM in both experimental groups suggest .that 
the "cold" L-tryp at that concentration would have saturated the 
non-specific binding sites of the synaptosomal preparations and 
subsequently have bound to the specific sites, thus effectively 
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reducing the binding levels of "hot" L-tryp. 
concentration DPM readings/mg protein significance 
of mixed "hot" ± S.E.M. 
and "cold" students 
L-tryp soln Test group Control group t test 
(roM) 
0,01 7 905,3 ± 205 5 370,31 ± 167 P < 0,01 
0,05 11 498,7 ± 403 5 697,1 ± 157 P < 0,01 
0,10 6 067,2 + 357 4 411,5 + 190 P < 0,05 
TABLE 14. effect of testosterone on L-["C)-tryptophan uptake by 
rat cortical synaptosomes. Rats were dosed with 0, 1ml 
testosterone twice daily for 5 days. They were 
sacrificed on the 6th day and the brains assayed for 
tryptophan uptake. Control rats were dosed with the 
vehicle. 
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4.1.4 
4.1.4.1 
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EFFECT OF ESTRADIOL AND PROGESTERONE ON L-[UC]-
TRYPTOPHAN UPTAKE BY RAT CORTICAL SYNAPTOSOMES 
Materials and Methods 
Twenty female rats weighing between 200 and 250g were used for 
this study. Fiye rats each in the Test and Control groups were 
respecti vely dosed with 0, 1ml progesterone or estradiol, and 
olive oil twice daily for 5 days. The rats were sacrificed on 
the 6th day and the uptake of L-["Cl-tryptophan in the brains 
was determined as described in 4.1.2.3. 
4.1.4.2 Results 
As shown in Tables 15 and 16; Figs. 31 and 32. 
Progesterone 
raised the 
and estradiol, 
uptake levels 
synaptosomal preparations. 
4.1:.4.3 Discussion 
like testosterone significantly 
of L- [HC l-tryptophan in the 
As outlined in 4.1.3.3., the elevated levels of L-["Cl-
tryptophan uptake by the synaptosomes from the brains of the 
rats dosed with the sex steroids relative to the controls may be 
a compensatory mechanism effected by the sex steroids to make up 
for the depressed levels of circulating tryptophan a 
consequence of the inductive effect of the sex steroids on 
hepatic tryptophan pyrrolase activity. 
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Concentration DPM readings/mg protein significance 
of mixed "hot" ± S.E.M. 
and "cold" students 
L-tryp soln Test group Control group t test 
(roM) 
0,01 8 169,5 ± 304 5 420,1 ± 153 P < 0,01 
0,05 12 970,3 ± 351 7 271,8 ± 257 P < 0,01 
0,10 6 12~,2 + 157 4 46Z,7 + 103 P < 0,05 
TABLE 15. effect of progesterone on L-[1'C]-tryptophan uptake by 
rat cortical synaptosomes. Rats were dosed with 0, 1ml 
progesterone twice daily for 5 days. They were 
sacrificed on the 6th day and the brains assayed for 
tryptophan uptake. Control rats were injected with 
olive oil. 
Concentration DPM readings/mg protein significance 
of mixed nhot" ± S.E.M. 
and "cold" students 
L-tryp so In Test group Control group t test 
(roM) 
0,01 5 180,7 ± 97 5 420,8 ± 120 N.S. 
0,05 13 135,3 ± 303 7 271,7 ± 187 P < 0,01 
0,10 8 8~9,1 + 236 4 !\67,3 + 121 P < 0,01 
TABLE 16. effect of estradiol on L-[HC]-tryptophan uptake by 
rat cortical synaptosomes. Rats were injected with 
O,lml estradiol twice daily for 5 days. They were 
sacrificed on the 6th day and the brains assayed for 
tryptophan uptake. Control rats were dosed with 
olive oil. 
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5.1 CONCLUSION 
5.1.1 INTRODUCTION 
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CHAPTER 5 
The primary objective of this work was to investigate firstly , 
the effect of the gonadal sex steroids on hepatic tryptophan 
pyrro1ase activity; secondly the physiological implications of 
this effect on circulating levels of tryptophan; thirdly, the 
biochemical manifestations of these two effects on the 
biosynthesis of various indoles in the pineal gland of castrated 
male rats and ovariectomized female rats; and finally to 
observe how the brain uptake of L-tryptophan would be affected 
by the various sex steroids. 
5.1.2 HEPATIC TRYPTOPHAN PYRROLASE ACTIVITY 
Kynurenine concentration was quantitatively determined and this 
was plotted as a function of time in the linear phase for all 
the three sex steroids. There was a significant inductive 
effect by the steroids on liver tryptophan pyrrolase activity. 
The concentrations of the sex steroids administered were 
pharmacological rather than physiological and this might explain 
their inductive actions. Relative to testosterone and 
estradiol, progesterone appears to exert the highest level of 
induction of tryptophan pyrrolase activity. 
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The biochemical implication involves the following possible 
mechanism : In pharmacologi cal concentrations, the sex steroids 
could stimulate liver tryptophan pyrrolase, "shunting" the brain 
and pineal metabolism of L-tryptophan in favour of the oxidative 
kynurenine-nicotinic acid metabolic pathway. The consequence is 
reduced levels of circulating tryptophan and reduced serotonin 
production in the brain. Deficiency of functionally- active 
brain serotonin has been implicated in certain depressive 
disorders (Lapin and Oxenkrug, 1969). 
Ovariectomy and castration significantly brought about depressed 
levels of liver kynurenine relative to intact controls as well 
as castrated and ovariectomized rats which were dosed with the 
appropriate steroid. The highest kynurenine concentrations and 
therefore the highest enzyme activity were found in castrated 
and ovariectomized rats dosed with the steroid. This reinforces 
the induction concept of liver tryptophan pyrrolase by the 
gonadal sex steroids. 
5.1. 3 
5.1.3 . 1 
METABOLISM OF HC- SEROTONIN BY RAT PINEAL ORGAN 
CULTURES 
Introduction 
The technique of organ culture was used to observe the direct 
effects of various chemical agents on HC-serotonin metabolism 
by the rat pineal gland. Much of the work reported in the 
literature on this aspect of p i neal biochemistry has been done 
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mainly on the two pineal enzymes, SNAT and HIOMT. However, this 
study investigated the relative levels of the various indole 
metabolites of HC-serotonin under different experimental 
conditions of organ culture. SNAT and HIOMT are the dominant 
pineal enzymes involved in the biosynthesis of the various 
indoles in the pineal gland and therefore the relative levels of 
the indoles in a~y particular experimental condition of organ 
culture would be a reflection of the relative activities of 
these pineal enzymes. 
5.1.3.2 Effect of gonadal sex steroids on HC-serotonin 
metabolism 
5.1.3.2.1 Testosterone 
The predominant indole found in all the organ culture studies 
was 5-HIM. castration of male rats resulted in depressed 
levels of MEL, HIM, MIM and HTOH relative to intact controls 
as well as castrated animals whose pineals were incubated with 
testosterone. castration of male rats have been found to 
(i) exert inhibitory effects on pineal HIOMT activity (Nagle et 
al., 1974), 
(ii) cause a decrease in pineal concentration of cAMP (Karasek 
et al., 1978). 
The finding that the levels of the various indoles in the 
pineals from castrated rats which were incubated with 10nM 
testosterone were higher relative to the other two groups 
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suggests that testosterone might play a modulatory role in the 
activities of HIOMT and SNAT. 
oaya (1985) observed that the stimulatory activity of 
testosterone is not dependent on prior conversion of 
testosterone to estradiol, suggesting a direct action of 
testosterone. In contrast, Cardinali et al., (1974) found that 
the rat pineal can aromatize radiolabelled testosterone into 
estradiol prior to exerting biological activity. The 
concentration of testosterone used in this study was in the 
physiological concentration range. It was therefore not 
possible to determine what effect pharmacological concentrations 
of testosterone would have on SNAT. Testosterone was the only 
steroid capable of probably influencing SNAT activity in this 
study. 
5.1.3.2.2 Progesterone 
The levels of MEL, HIM and HTOH in the ovariectomized rat 
pineal cultures incubated with progesterone were significantly 
higher than the pineal cultures incubated with the vehicle. 
This suggests that at physiological concentrations, progesterone 
has a stimulatory role in the melatonin synthesis pathway. 
Reports on the effects of progesterone on HC-serotonin 
metabolism in pineal organ cultures are few. Oaya (1982) 
observed a biphasic dose-dependent effect of progesterone on 
HIOMT activity. 
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5.1.3.2.3 Estradiol 
The results here show a significant increase in the MEL levels 
with a concomitant decrease in NAS levels in the ovariectomized 
rat pineal cultures incubated with estradiol relative to 
ovariectomized rat pineals incubated with the vehicle as well as 
the intact controls. Estradiol might probably have potentiated 
HIOMT acti vi ty but not SNAT acti vi ty • The concentration of 
estradiol used was in the physiological range; however, Mizobe 
and Kurokawa, (1976) have established that estradiol influences 
HIOMT activity in a biphasic dose-dependent manner. 
That estradiol has no modulatory effect on SNAT activity lends 
support to Daya's (1985) observation that testosterone does not 
depend on prior conversion to estradiol before exerting 
biological acti vi ty since testosterone was found in Daya' s 
(1982) study to stimulate SNAT activity. 
5.1.4 
5.1.4.1 
EFFECT OF GONADAL SEX STEROIDS ON THE NIGHTTIME 
METABOLISM OF uC-SEROTONIN BY RAT PINEAL ORGAN 
CULTURES 
Testosterone 
Comparing these nighttime results to the daytime study, the 
levels of MEL were significantly higher in the former study. 
The diurnal variation in pineal melatonin synthesis was 
therefore evident. From the relative levels of indoles in the 
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various experimental groups, castration resulted in a decrease 
in the nocturnal elevation of MEL levels. castration therefore 
possibly depresses SNAT nocturnal activity. Testosterone 
replacement restored the reduced nocturnal MEL levels. 
5.1.4.2 Estradiol 
Ovariectomy brought about reduced MEL synthesis comparing the 
various experimental groups. There were signficantly higher MEL 
levels in the pineal cultures of intact rats compared to the 
pineals from ovariectomized rats which were incubated with 
estradiol as well as pineals from ovariectomized rats which were 
incubated with the vehicle. 
In this study, estradiol, once again, was found to have no 
modulatory effect on the melatonin synthesis pathway. 
5.1.5 CUMULATIVE EFFECT OF TESTOSTERONE AND ISOPRENALINE ON 
HC-SEROTONIN METABOLISM IN ORGAN CULTURE 
Isoprenaline, a B-adrenergic agonist, like norepinephrine can 
stimulate cAMP formation via the B-adrenergic mechanism for 
enhanced production of pineal melatonin. In this study, 
testosterone was found to potentiate the isoprenaline response. 
5.1.6 
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EFFECT OF GONADAL SEX STEROIDS ON L- [HC] -TRYPTOPHAN 
UPTAKE BY RAT CORTICAL SYNAPTOSOMES 
All three sex steroids used in this study significantly enhanced 
the uptake of L-tryptophan by the cortical synaptosomes. This 
may be interpreted as a compensatory mechanism effected by the 
sex steroids to make up for the reduced levels of circulating 
tryptophan - a consequence of the induction of liver tryptophan 
pyrrolase activity by the gonadal sex steroids. 
5.1. 7 GENERAL 
The gonadal sex steroids significantly influenced the daytime as 
well as the nighttime levels of various indoles in the course of 
the metabolism of HC-serotonin by rat pineal organ cultures. 
considering the relative indole levels, it becomes evident that 
the sex steroids exerted modulatory effects on HIOMT activity. 
In case of SNAT, it was only testosterone which might have 
possibly stimulated this enzyme bringing about enhanced 
synthesis of melatonin. 
Testosterone would therefore appear to play certain 
biochemically vital roles in the regulation of pineal function. 
There have been numerous reports on the effect of pineal 
function on regulation of the gonads but very little information 
on the regulation of pineal function by the sex steroids is 
available. From the results, it does appear that the sex 
176 
steroids have salient modulatory roles in the regulation of 
pineal biochemistry. The pineal gland therefore appears to be 
a target hormone for the sex gland. 
CHAPTER 1 
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CHAPTER 6 
SUMMARY 
A comprehensive overview of the location, anatomy, morphology, 
circadian rhythms and various biochemical interactions between 
the pineal gland and the gonads (mediated by the gonadal sex 
hormones and melatonin, a putative hormone) was discussed. Also 
discussed was the biochemical significance of the regulatory 
roles played by the sex steroids on liver enzyme, tryptophan 
pyrrolase, and the relevance of these roles in certain clinical 
disorders. 
CHAPTER 2 
The effects of testosterone, estradiol and progesterone on liver 
tryptophan pyrrolase activity were investigated. All the three 
sex steroids significantly brought about induction in the enzyme 
activity with progesterone demonstrating the highest level of 
induction. The concentration of all the sex steroids used was 
above the physiological range. 
ovariectomy and castration significantly brought about 
depression in tryptophan pyrrolase activity. 
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CHAPTER 3 
The effects of the gonadal sex steroids on the levels of various 
indo1eamine metabolites in the metabolism of HC-serotonin by 
pineals from ovariectomized and castrated rat organ cultures 
during the daytime as well as the nighttime were investigated. 
The nocturnal levels of MEL were relatively higher in the two 
time groups, a finding consistent with previous reports on the 
circadian variation of melatonin synthesis. The testosterone-
treated cultures were found to have higher levels of the various 
indoles, particularly MEL, MlAA and HTOH relative to the other 
cultures treated with the vehicle. This strongly suggested a 
stimulatory effect of testosterone on SNAT and HIOMT, the two 
prominent enzymes in the indoles synthesis pathways. 
Comparing the relative indole levels in the various cultures, it 
does appear that estradiol and progesterone positively 
influenced HIOMT activity even though they probably failed to 
modulate SNAT acti vi ty. Since only physiological concentrations 
of these hormones were used in these studies, it would not be 
possible to comment on how the activities of the two pineal 
enzymes would respond to very high (pharmacological) or very low 
steroid concentrations. 
castration and ovariectomy were found to depress the levels of 
the various indole metabolites. However, ovariectomy and 
treatment with estradiol and progesterone did not affect MEL 
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levels in the various cultures. 
nocturnal elevation in MEL levels. 
restored these levels. 
castration depressed the 
Testosterone replacement 
The cumulative effect of testosterone and isoprenaline on MEL 
levels in rat pineals in organ cultures was also investigated. 
MEL levels in cultures incubated with isoprenaline and 
testosterone together were significantly higher than those in 
cultures incubated with testosterone alone or with the vehicle. 
This suggested a potentiation of the isoprenaline response by 
testosterone. 
CHAPTER 4 
The influence of the gonadal sex steroids on the uptake of 
radiolabelled tryptophan by rat cortical synaptosomes was 
investigated. This study involved using three solutions of 
mixed "hot" and "cold" tryptophan of different concentrations. 
There was a significant increase in tryptophan uptake in the 
incubation media of all three sex hormones as well as controls 
from a concentration of 0, 01mM to 0, 05mM but the uptake was 
found to decrease from O,05mM to O,lmM in all the experimental 
groups. 
The results also suggest that the gonadal sex steroids 
significantly enhanced the level of tryptophan uptake by the 
cortical synaptosomal preparations, relati ve to the control 
group. As explained previously, this may be a compensatory 
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mechanism effected by the sex steroids to make up for the 
reduced levels of circulating tryptophan - a consequence of 
induction of liver tryptophan pyrrolase activity by the gonadal 
sex steroids. 
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Protein concentration (~g/ml) 
Appendix 1. Protein standard curve. 
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